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Chapter 1 
Introduction 
Pathological processes in the artery wall 
submitted for publication in a modified form 

PATHOLOGICAL PROCESSES IN THE ARTERY WALL 
Cardiovascular disorders are the chief cause of death in Western Europe and the United 
States (Report of the Working Group of Atherosclerosis, 1981). Among them, hypertension 
constitutes a major public health problem with a largely unknown etiology afflicting more 
than fifteen percent of the citizens of the western world. Naturally, this situation has drawn 
much attention from cell biologists and biochemists. Stimulated by our rapidly expanding 
knowledge of growth factors and their receptors the number of biochemical studies on the 
vascular system has grown exponentially in the last decade. Yet, despite the proliferation of 
papers in this field, some basic questions concerning the primary causes of hypertension 
and atherosclerosis still remain unanswered. 
With the present review we intend to give a sketch of this complicated field and to indicate 
the barriers that at the moment block new vistas. We will summarize the current biochemical 
aspects of mechanisms of growth control of vascular cells in hypertension and atherosclerosis 
focussing on gene expression, DNA synthesis and growth regulation through the action of 
growth factors especially basic fibroblast growth factor (bFGF). Biochemical aspects of the 
cholesterol and lipid metabolism are beyond the scope of this review (for review on these 
subjects see: Goldstein and Brown, 1983; Schaefer and Levy, 1985; Schonfeld, 1990). 
THE ARTERY WALL 
The blood vessel wall is entirely derived from the mesoderm. However, it has its own 
distinctive layers or tunics. The innermost layer, the tunica intima, is composed of a 
monolayer of endothelial cells and underlaying connective tissue. It is separated from the 
middle layer by the internal elastic lamina. This middle layer, the tunica media, forming the 
bulk of the artery wall, is made up of many layers of smooth muscle cells surrounded by 
elastic fibers. The outermost layer, the tunica adventitia, is composed of connective tissue 
elements and contains small blood vessels and nerves (Morse, 1979) (figure 1). During 
growth the medial layer thickens. This is caused by the production of elastins and collagens 
and by increase of the smooth muscle cell number and mass (Looker and Berry, 1972; 
Olivetti et al., 1980). However, within a given species, the number of smooth muscle layers 
seems to be fixed (Wolinsky and Glagov, 1967). In mice made transgenic for growth 
hormone, Dilley and Schwartz (1989) observed an increase in the thickness of the artery 
wall to compensate for the increased blood pressure. However, even in this situation the 
number of smooth muscle layers remained constant. 
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Figure 1. Cross section through the artery wall. elements 
Illustration courtesy: Natuur & Techniek, Maastricht, The Netherlands 
THE EFFECT OF HYPERTENSION ON THE ARTERY WALL 
The tunica media, particularly that of the the small muscular arteries regulates blood flow 
and pressure by modulating the diameter of the lumen of these vessels. By reducing the 
blood flow metabolic exchanges across the capillary wall are stimulated (Schwartz et al., 
1990b). Hypertensive vessels are characterized by a narrowed lumen as a result of an 
increased contraction of the smooth muscle cells leading to an increased thickness of the 
tunica media (Takeshita and Mark, 1980; Wiener and Giacomelli, 1983). Folkow et al. 
(1973), however, explained the thickening of the vessel wall in established hypertension as 
an adaptation to the increased peripheral resistance. If such an adaptation would indeed exist, 
it would mean that frequent periods of hypertension would promote chronic hypertension. 
This question is not yet resolved. In large vessels, increased wall thickness is caused by an 
increase of the mass of the smooth muscle cells (hypertrophy) which is associated with 
polyploidy (Olivetti et al., 1980). Owens et al. (1981) found a fixed ratio between protein 
and DNA content of medial vascular smooth muscle cells in the large arteries of 
normotensive and spontaneously hypertensive rats. In spontaneously hypertensive rats and 
Goldblatt renal hypertensive rats, the percentage of polyploid cells increased with age and 
correlated well with the increase in blood pressure (Owens and Schwartz, 1982; Owens and 
Schwartz, 1983). However, there is evidence from studies in spontaneously hypertensive rats 
that polyploidy precedes the onset of hypertension (Lee, 1985; Smeda et al. 1988). 
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Likewise, when Loeb et al. (1986) treated Goldblatt renal hypertensive rats with a DNA-
synthesis inhibitor they observed a delay in the development of hypertension. One should 
not conclude from these observations that hypertension is caused by polyploidy. The wall 
thickness of large arteries does not significantly contribute to hypertension. In small vessels, 
on the other hand, the percentage of polyploid cells does not seem to depend upon 
hypertension (see below). A population of tetraploid smooth muscle cells is also present in 
large arteries of humans (Barret et al., 1983). Their abundance increases with age and 
hypertension (Rosen et al., 1985). 
In order to elucidate the initiation and progression of polyploidy in arterial smooth muscle 
many in vitro studies were carried out. Rosen et al. (1985) observed that increased smooth 
muscle cell ploidy is associated with a decreased rate of proliferation in cultures derived 
from the normal rat aorta. In contrast, Gordon et al. (1986) observed no difference in 
growth rate between diploid and polyploid smooth muscle cell cultures. Even more in 
contrast with the findings of Rosen, Haudenschild et al. (1985) and likewise in another type 
of model system Hamada et al. (1990) described an enhanced proliferation of cultured 
vascular smooth muscle cells from aortae of hypertensive rats compared with cells from 
normotensive rats. It should be noted that the authors of these two publications did not make 
subclones of diploid and tetraploid smooth muscle cells and, therefore, could not establish 
how much the diploid cells participated in the observed activities. Van Neck et al. (1992) 
used such subclones to show that the amount of mRNA synthesized per smooth muscle cell 
is proportional to the average ploidy in the culture. This finding is in agreement with in vivo 
studies mentioned above reporting constant DNA/protein ratios in diploid and tetraploid cells 
(Owens et al., 1981) and in associating increased wall thickness in large vessels with the 
polyploidy of smooth muscle cells (Olivetti et al., 1980). Taken together, and despite the 
observations of Rosen et al. (1985), these studies support those carried out in vivo 
suggesting that polyploidy precedes the establishment of chronic hypertension and stays on 
if, later, hypertension is suppressed. 
In contrast to the described hypertrophy in large arteries, in hypertensive mesenteric arteries 
the increased DNA content reflects an increase in the number of smooth muscle cells 
(hyperplasia) (Mulvany et al., 1985; Black et al., 1988; Owens et al., 1988; Lombardi et 
al., 1989). In these small vessels, both hypertensive and normotensive rats showed 
increased, but comparable, numbers of polyploid cells with aging. The number of smooth 
muscle cell layers also remained constant (Lombardi et al., 1989). Thus, in smooth muscle 
cells hypertension apparantly has two different effects, hyperplasia in small vessels and 
hyperploidy in large vessels. Both mechanisms will give rise to an increased DNA load and 
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an increased deposit of collagen and elastin fibers in response to largely unknown stimuli. 
ATHEROSCLEROSIS 
In the fetus, the aortic endothelium lies directly on the internal elastic lamina (Morse, 1979). 
With age, the tunica intima thickens due to the addition of elastin and collagen fibers and 
the outgrowth of smooth muscle cells. (Homblad, 1971; Ross and Roberts, 1986). The 
increase with age is a constant process (Stary, 1989). Intimai thickening may be viewed as 
a prerequisite for the development of the atherosclerotic lesions since the smooth muscle cell 
is the principal mesenchymal cell in the human atherosclerotic plaque (Haust et al., 1960). 
Thus, atherosclerosis can be viewed as a disorder of the tunica intima in which excessive 
increase in the amounts of the extracellular matrix and the number of smooth muscle cells 
are predisposing to plaque formation (French, 1966; Velican and Velican, 1976). 
In humans, the earliest lesion of atherosclerosis is the fatty streak, a lipid rich lesion 
containing both macrophages and smooth muscle cells (Ross, 1986). The fibrous plaque is 
a typical form of advanced atherosclerosis, made up of intimai smooth muscle surrounded 
by a connective tissue matrix that contains variable amounts of intracellular and extracellular 
lipids and is usually covered by a dense fibrous cap of smooth muscle cells and connective 
tissue (Ross, 1986). The fibrous plaques are generally believed to develop from fatty streaks 
since fatty streaks are often found in early life at the same anatomical sites where smooth 
muscle cells rich fibrous plaques develop at older age (Robertson et al., 1963; McGill, 
1984). 
Two seemingly conflicting hypotheses try to explain the onset and development of the 
atherosclerotic plaque, the "monoclonality hypothesis" of Benditi and the "response-to-
injury hypothesis" of Ross. 
The monoclonality hypothesis 
Benditi and Benditi (1973) analyzed the segregation of X-linked genes coding for isoenzymes 
of glucose-6-phosphate dehydrogenase in the smooth muscle cells of an atherosclerotic 
plaque in heterozygous females. It was found that most plaques contained a single isoenzyme 
whereas tissue of the normal artery wall always contained a mixture of both isoenzymes. 
Consequently, the forming of the atherosclerotic plaque must be the result of a mono- or at 
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least oligoclonal smooth muscle cell proliferation perhaps like the benign, slow growing, 
smooth muscle tumors of the uterus. This would imply a neoplastic origin of the smooth 
muscle cell in a plaque (Benditi and Gown, 1980). The monoclonahty hypothesis therefore 
suggests that plaques might anse through mutational events or viral infections. Studies with 
cockerels supported this hypothesis as injections with carcinogens elicited the appearance of 
plaques in the abdominal aorta (Benedict et al., 1973). Other studies discovered the presence 
of enzymes that metabolize these carcinogens in the artery wall (Bond et al., 1979; Majesky 
et al., 1983). Indeed, cockerels injected with the oncogenic Marek's disease virus, an avian 
herpes virus, displayed microscopic plaques (Fabncant et al., 1978; Fabncant et al., 1983; 
Minick et al., 1979). Melmck et al. (1983) descnbed the presence of cytomegalovirus 
antigen in human artenal smooth muscle cells. Similarly, Benditi et al. (1983) descnbed the 
presence of herpes simplex viral mRNA in human artery wall tissue sections of many 
individuals with evidence of atherosclerosis and demonstrated the ability of herpes simplex 
virus to infect human smooth muscle cells in vitro. In another experimental approach 
inspired by the monoclonahty hypothesis, Penn et al. (1986) searched for and found 
sequences in human atherosclerotic plaque DNA that were able to transform NIH 3T3 cells 
whereas normal coronary artery was negative in this assay. Similar results were reported by 
Ahmed et al. (1990). 
How much evidence have we really that atherosclerosis is caused by the focal growth of 
smooth muscle cells in the artenal wall in a way that resembles an benign tumongemc 
process? The monoclonahty hypothesis does not sufficiently explain the onset of 
atherosclerosis in almost all adult humans at many sites m the large vessels. The follow up 
of the expenments of Penn is rather scarce, so far. Furthermore, the involvement of viruses 
in the etiology of atherosclerosis in humans is complicated and unclear since the percentage 
of individuals positive for herpes simplex virus is high. However, none of these objecnons, 
circumstantial as they may be, ngorously invalidates Benditt's hypothesis which, therefore, 
still deserves senous consideration. 
II) the response-to-injury hypothesis 
Virchow (1856) aheady postulated a response-to-injury concept. He viewed artenosclerosis 
as an inflammatory process induced mechanically by the impact of blood flow on endothelial 
cells. Indeed, atherosclerotic plaques are often predominantly found at bifurcation-sites 
where the blood flow induces severe wall stress. Ross (1986) modified this concept and 
postulated the response-to-injury hypothesis. He supposed the smooth muscle cell 
proliferation to be the result of an inflammatory reaction to injury with release of growth 
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factors from platelets, macrophages and cells present in the vessel wall (figure 2). Many data 
that support this will be discussed in the following sections. According to this theory, the 
basis of the release of growth factors lies in injury of the endothelium leading to a loss of 
the non-thrombogenic character of the vessel wall, adhesion of blood platelets and exposure 
of the subendothelial layers to mitogens from the blood or from the injured cells of the 
vessel wall. 
The monoclonality hypothesis and the response-to-injury hypothesis are not necessarily 
mutually exclusive. The limited available data on the embryology of the vasculature indicate 
that smooth muscle cells may be recruited locally (Ekblom et al., 1982; Schwartz et al., 
1990b). Thus, it could well be that vascular smooth muscle cells descend from more than 
one type of precursor cell or develop into phenotypically different subsets of cells (van 
Neck et al. submitted). Predisposition for focal outgrowth into atherosclerotic lesions could 
be unequally distributed among the subtypes. This would then explain the observations by 
Benditt and Benditi (1973) on which the monoclonality hypothesis is based. There are a 
number of data that indeed point in that direction. 
In the avian aorta two smooth muscle cell phenotypes can be recognized (Moss and Benditt, 
1970a; Moss and Benditt, 1970b; Wight et al, 1977). In the normal mammalian vessel wall 
poorly differentiated cells can be seen (Gabbiani et al, 1984; Kocher and Gabbiani. 1984; 
Kocher and Gabbiani. 1986). Moreover, in the microvasculature, the pericytes, these are 
Endolhelium Macrophages Smooth muscle cell Detritus 
Haldeta Ь Macrophages
 c
 Smooth muscle 
Figure 2. Development of the atherosclerotic plaque according to the response-to-injury hypothesis. 
Macrophages and platelets attach to the injured endothelium (a). Growth factor release by 
these cells will stimulate the migration of smooth muscle cells from the media to the intima 
(b). Continuation of this proces, together with lipid and detritus deposit, will lead to 
fibrous plaque formation and further lesion progression (c). 
Illustration courtesy: Sandoz, Uden, The Netherlands. 
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cells very similar to smooth muscle cells that surround the endothelium and regulate the 
microvascular blood flow through their contractile activity, show a heterogeneous 
morphology (Herman and d'Amore, 1985). These observations suggest that the population 
of vascular smooth muscle cells is not homogeneous, some subsets of smooth muscle cells 
being more susceptible than others to certain growth factors that may lead to an oligoclonal 
proliferation in response to injury. Clearly, more experimentation is needed to establish a 
generally accepted theory on the cause and development of atherosclerosis. 
Endothelial injury 
A simple way to determine the role of the endothelial layer in atherogenesis is to study the 
effects of its removal. The most commonly used method for denuding blood vessels of 
endothelium is balloon catheterization (Baumgartner et al., 1966). Balloon catheterization 
of arteries causes immediate endothelial denudation, with platelet adherence to the exposed 
subendothelium. At the site of the lesion a pronounced intimai thickening develops in a few 
days (Groves et al., 1979; Haudenschild and Schwartz, 1979; Clowes et al., 1983). These 
findings seem to support the hypothesis that endothelial cell loss is the first step in the 
formation of atherosclerotic lesions. Balloon catheterization severely damages the vessel 
wall. In the rat carotid artery a loss of 20 percent of the DNA-content of the vessel wall was 
observed (Clowes et al., 1983). This loss must reflect the loss of smooth muscle cells since 
the monolayer of endothelial cells does not contribute much to the total amount of DNA in 
the vessel wall. Reidy and Schwartz (1981) made use of a flexible nylon filament and 
removed only a small zone of the endothelium. This also caused immediate platelet 
adherence. However, smooth muscle cell replication in these arteries was ten times lower 
than that in arteries denuded with the balloon catheter. Under these circumstances a severe 
intimai lesion formation never was observed (Fingerle et al, 1990). Moreover, the removal 
of a wide area of endothelium by means of this method also failed to cause intimai 
thickening (Reidy and Silver, 1985). Electron microscopy of vessels denuded in this way did 
not reveal injury of the medial layer (Reidy, 1985). Removal of a small area of endothelium 
with the use of a steel wire, that disrupts the internal elastic lamina, caused a pronounced 
intimai thickening (Walker et al., 1983). Clearly, it is the trauma to the tunica media, rather 
than endothelial loss or platelet adherence that leads to smooth muscle cell proliferation 
(Bjorkerud, 1969; Bjorkerud and Bondjers, 1971; Reidy, 1985; Fingerle et al., 1990). This 
conclusion suggests a role for endogenous factors possibly released from injured cells within 
the vessel wall. 
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Another aspect of the response-to-injury hypothesis is that the definition of endothelial injury 
is problematic since injury does not necessarily come along with morphologic changes. One 
complicating factor is the occurrence of a so called "pseudo-endothelium" (Clowes et al., 
1978; Clowes et al., 1983). Pseudo-endothelium is formed by smooth muscle cells after a 
prolonged absence of the endothelium. The smooth muscle cells covering the surface then 
become non-thrombogenic (Groves et al., 1979; Reidy et al., 1983; Manderson et al., 1989) 
and, at least in the rat, strongly resemble the endothelial morphology (Reidy et al., 1983; 
Schwartz et al., 1990a). 
The formation of a pseudo-endothelium does not occur in the case of a minor injury. To 
explain the repair of superficial damage to the endothelial monolayer, Reidy and Schwartz 
(1984) proposed a mechanism involving endothelial cell replacement by spreading of adjacent 
cells without any loss of integrity which they called "non-denuding desquamation". In the 
rat, small injuries, requiring less than 8 h of cell movement, were healed by rapid cell 
migration and not by growth of cells (Reidy and Schwartz, 1983). In experiments where an 
endotoxin, as a non-mechanical agent, was used to injure the endothelium, it was observed 
that cell denudation and cell replacement occurred simultaneously without platelet adherence 
(Reidy and Schwartz, 1981; Reidy and Schwartz, 1983). Repair of small injuries by "non-
denuding desquamation" is probably driven by cell-cell communication. An equivalent of 
non-denuding desquamation is observed in vitro in experiments that monitor the exclusion 
of a vital dye on cultured endothelial cells (Hansson and Schwartz, 1983) as well as by time-
lapse video microscopy (Hansson et al., 1985; Reidy and Schwartz, 1983). Several groups 
have been studying experimentally injured endothelium by describing cell shape 
(Christensen, 1974; Repin et al., 1984), changes in cell junctions (Robertson and Khairallah, 
1973) and differences in staining with osmium and silver nitrate (Hansson et al, 1979; 
Gerrity, 1981). These examples illustrate the problems in recognizing endothelial injuries 
especially when we bear in mind that a morphologically normally appearing endothelial cell 
surface still may be injured and secrete growth factors. 
Fingerle et al. (1989) showed that a temporary absence of platelets, due to treatment with 
anti-platelet antibodies, did not make any difference to the early events of the smooth muscle 
cell proliferation. However, the total intimai thickening after one week was limited. On the 
other hand, when they used a nylon filament to obtain a gentle denudation, platelets did 
adhere to the vessel wall with no marked smooth muscle cell proliferation (Fingerle et al., 
1990). These data indicate that extended smooth muscle cell proliferation is a consequence 
of the disruption of the arterial wall which possibly released growth factors into the 
extracellular micro-environment. Adherence of platelets solely played a role in the 
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Stimulation of smooth muscle cell migration. Not quite in agreement with these results are 
observations by Reidy (1990). He found smooth muscle cell proliferation at sites distant 
from a vascular injury in the absence of visible trauma or platelet adherence. Induction of 
this proliferation by growth factor release of the vessel wall cells is not plausible since this 
would lead to a higher proliferation of the downstream cells due to the blood flow which did 
not seem to be the case. The stimulus for the proliferation is unknown. Apparently, some 
form of cell communication generated by the mechanical injury must be involved. 
Endothelial repair is limited. After complete endothelial denudation of an artery the 
endothelial regrowth stopped after 5 - 6 weeks (Reidy et al, 1982; Reidy et al., 1983; 
Heimark and Schwartz, 1985). Recently studies show an involvement of basic fibroblast 
growth factor (bFGF) in endothelial cell replication and, consequently, repair of injury 
(Lindner et al., 1991; Lindner and Reidy, 1991; Cuevas et al., 1991). We will come back 
to bFGF later. 
Smooth muscle ceil proliferation 
The presumed monoclonality of atherosclerotic plaques suggests that only a limited number 
of smooth muscle cells in the vessel wall proliferate. However, in contrast to several studies 
on cell proliferation in animal model systems (Scott et al., 1985; Walker et al., 1986; Kim 
et al., 1987; Kim et al, 1988), little is known about the cell replication rates in human 
arteries and in plaques. The number of DNA-synthesizing cells in normal arteries of both 
man and rat is extremely low as revealed by 3H-thymidine incorporation (Orekhov et al., 
1983; Villaschi and Spagnoli, 1983; Lombardi et al., 1991). Employing antibodies specific 
to proliferating cells, Gordon et al. (1990) found a moderately raised frequency of 
replicating cells in atherosclerotic plaques as compared to normal coronary artery segments 
(0.8 and 0.3 percent positive cells respectively). In balloon injured rat carotid arteries, on 
the other hand, up to 30 per cent of the cells scored positive after the addition of 3H-
thymidine for one hour (Clowes et al., 1983). The low labelling index in human arteries and 
plaques is consistent with the clinical observation that the development of atherosclerotic 
plaques in humans takes years and that established plaques often remain constant in size for 
years (Roederer et al., 1984; Brown et al., 1989). 
Involvement of growth factors in injury repair and smooth muscle cell proliferation 
Understanding growth control of smooth muscle cells is very important as abnormal growth 
of these cells characterizes the pathology of both hypertension and atherosclerosis. 
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In the normal vessel wall smooth muscle cell growth may be controlled by growth factors 
released from blood cells or from the vessel wall cells themselves, by growth inhibitors 
derived from the vessel wall or by other forms of control such as cell-cell contact which also 
can be mediated by growth factor release (Schwartz et al., 1990b). In this respect the 
endothelium serves as an interface between the smooth muscle cells and the blood. Several 
growth factors can be produced by the types of cells present in the atherosclerotic vessel 
wall, that is platelets, macrophages, endothelial cells and smooth muscle cells (Ross, 1986; 
Benditi, 1988; Schwartz et al., 1990b). Endothelial injury may render the underlaying tissue 
accessible to growth factors derived from platelets or leucocytes, particularly platelet-
derived growth factor (PDGF) and to basic fibroblast growth factor (bFGF) derived from 
the endothelium itself. 
In the following sections, various relevant growth factors will be discussed. Together they 
form a complex network that coordinates the functions of many different cell types. 
Unfortunately, this network has not yet been completely unraveled and, at this moment, any 
schematic representation would be unsatisfactory. 
Platelet derived growth factor (PDGF) 
PDGF is composed of two disulfide-linked chains termed A and В that are encoded by 
separate genes (Betsholz et al., 1986). All three possible hetero- and homo-dimers of A and 
В chains exist under natural conditions (Ross et al., 1986; Hammacher et al., 1988). High 
affinity binding sites are found on many cells of mesenchymal origin including smooth 
muscle cells. They have an intrinsic protein tyrosin kinase activity and consist of two 
subunits (Ronnstrand et al., 1987). PDGF-receptors are homo- or hetero-dimers of a- and 
ß-subunits. a-subunits bind to either PDGF-chain and ß-subunits only bind to B-chains 
(Seifert et al., 1989; Heldin and Westermark, 1989). Both receptors seem to have mitogenic 
capacity (Seifert et al., 1989; Williams, 1989). In rat vascular smooth muscle cells, PDGF-
AB and PDGF-BB posess a chemotactic activity and induce the same effects (DNA synthesis 
stimulation, diacylglycerol formation, calcium mobilization, pH changes) whereas PDGF-
AA shows no chemotactic activity and gives a weak mitogenic response (Sachinidis et al., 
1990; Fems et al., 1991a), probably due to the low number of PDGF-receptor a subunits 
in these cells (Fems et al., 1991a). 
Cultured endothelial cells express and secrete PDGF but PDGF is not mitogenic for these 
cells that lack PDGF-receptors (Dicorleto and Bowen-Pope, 1984; Schwartz et al., 1990b). 
In vivo, however, the microvascular endothelium contains both PDGF and PDGF-receptors 
(Barrett et al., 1983; Hermansson et al., 1988). The level of PDGF expression can be 
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modulated by exposure to a variety of compounds including thrombin, catecholamines, 
transforming growth factor-ß (TGF-ß) and lipoproteins (Daniel et al., 1986; Daniel et al., 
1987; Fox and Dicorleto, 1986; Gajdusek et al., 1986; Starksen et al., 1987). PDGF-B 
secretion in cultured human endothelial cells strongly is reduced when the cells are grown 
in the presence of bFGF (Kourembanas and Faller, 1989). TFG-ß inhibited growth in 
endothelial cell cultures and increased the amount of secreted PDGF-B (Takehara et al., 
1987; Daniel et al., 1987). Since PDGF-B is a potent vasoconstrictor, these observations 
suggest that the regulation of PDGF-B may play an important role in maintaining and 
controlling the integrity of the vasculature (Berk et al., 1986). Thus, one could speculate that 
proliferative endothelial cells reduce their PDGF-B secretion and, as a result, 
vasoconstriction returns to normal after restoration of the vessel wall (Kourembanas and 
Faller, 1989). 
The presence of mRNA for PDGF in human atherosclerotic plaques suggested an autocrine 
mechanism for plaque growth. PDGF-B mRNA was found in association with endothelial 
cells and monocytes whereas PDGF-A mRNA was associated with smooth muscle cells 
(Wilcox et al., 1988; Barrett and Bendi«, 1988). Furthermore, the presence of PDGF В in 
plaques was identified and the expression of the PDGF-receptor ß-subunit was elevated in 
atherosclerotic plaques as compared to the normal wall (Wilcox et al., 1988; Ross et al., 
1990). Addition of an anti-PDGF-B antibody inhibited the accumulation of intimai smooth 
muscle cells after balloon catheterization in the rat (Ferns et al., 1991b). However, medial 
3H-thymidine labelling indices were the same for balloon injured rat aorta with or without 
anti-PDGF addition. Therefore, we have to conclude that PDGF merely evokes a 
chemotactic response on smooth muscle cells. In agreement with this conclusion, PDGF-
B injections strongly enhanced the size of the intimai lesions (Fems et al., 1991b). 
Other growth factors 
Other well characterized growth factors controling smooth muscle cell growth are TGF-ß, 
interleukin-1 (IL-1), insulin-like growth factor-I (IGF-I) and thrombospondin. TGF-ß is very 
abundant in platelets and can be secreted by vascular endothelial cells and smooth muscle 
cells in co-culture (Assoian and Spom, 1986; Antonelli-Orlidge et al., 1989). The properties 
of TGF-ß are complicated. It inhibited or stimulated smooth muscle cell growth depending 
on its concentration. At low concentrations it stimulates the production of PDGF-AA that 
induces proliferation by binding to PDGF-receptor a-subunits. At high concentrations of 
TGF-ß the proliferation as a response to PDGF-AA production is limited by downregulation 
of the PDGF-receptor a-subunit (Battegay et al., 1990). In confluent cultures of smooth 
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muscle cells TGF-ß also induced thrombospondin, a 450 kD secreted protein essential for 
smooth muscle cell proliferation (Majack et al., 1988; Majack et al., 1990). PDGF also is 
known to regulate thrombospondin synthesis (Majack et al., 1985). 
Not much is known about the role of EGF in smooth muscle cell growth. However, EGF 
can act as a mitogen of smooth muscle cells in vitro. It is present in blood platelets. 
Moreover, it is able to elicit contraction in the intact vessel wall (Oka and Orth, 1983; Berk 
et al., 1987). 
IL-1 is a cytokine produced by many cell types including endothelial cells. Endothelial cell 
growth in vivo and in vitro was inhibited by IL-1. This was probably the result of the IL-
1 induced suppression of FGF-receptors in the cell membrane (Cozzolino et al., 1990). On 
the other hand, IL-1 induces bFGF expression and subsequent growth stimulation in vascular 
smooth muscle cells (Gay and Winkles, 1991). Other cytokines such as TGF-ß and tumor 
necrosis factor a (TNF-or) enhance vascularization in vivo (Roberts et al., 1986; Frater-
Schröder et al., 1987; Leibovich et al., 1987). In vitro endothelial cells are able to 
synthesize several growth factors such as TGF-ß, bFGF, PDGF and IGF-I (Boes et al., 
1991). Subsequently, when the cells were exposed to one of these growth factors this was 
followed by downregulation of the corresponding receptor (Boes et al., 1991). Thus we are 
confronted with a complex picture of factors that regulate endothelial- and smooth muscle 
cell-growth and the endothelium as a self-regulating system in which growth control is 
maintained by modulating the expression of endogenous positive and negative mediators. 
IGF-I is an abundant compound of plasma. In cultured smooth muscle cells, IGF-I is 
required for the completion of the cell cycle after stimulation with PDGF (Clemmons, 1984; 
Russell et al., 1984). PDGF itself is able to induce IGF-I production in smooth muscle cells 
(Clemmons, 1984). However, because of its abundance in plasma, it is unclear whether or 
not there is any need for additional IGF-I production in vivo. 
Basic fibroblast growth factor (bFGF) 
bFGF is a cationic protein of about 18 kD. It belongs to the family of heparin binding 
growth factors and is widely distributed in tissues where it stimulates nerve generation, 
cartilage repair and is involved in normal cell growth (Cuevas et al., 1988; Danielsen et al., 
1988). During embryonic growth bFGF is a potent mesoderm inducer (Slack et al., 1987; 
Kimelman et al., 1988; Amaya et al., 1991; Slack, 1991) It is also a potent angiogenic 
factor (Thompson et al., 1986; Folkman and Klagsbrun, 1987). bFGF can be 
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immunolocalized in the cytoplasm as well as in the nucleus eg in endothelial cells, 
(Schulze-Osthoff et al , 1990; Dell'Era et al., 1991) The use of an AUG start codon gives 
nse to a cytoplasmic form of bFGF (Florkiewicz and Sommer, 1989, Bugler et al., 1991). 
However, when more upstream a CUG codon is used for translation initiation a stretch of 
37 amino acid residues, containing the signal for nuclear localization, is added to the N-
terminus of the protein (Quarto et al , 1991). Despite the absence of an obvious secretory 
signal sequence, bFGF also can be found outside the cell m the basement membrane where 
it is bound to low affinity receptors, belonging to the class of the heparan sulfate 
proteoglycans (HSPG) (Baud and Ling, 1987; Vlodavsky et al., 1987; Klagsbrun and Baird, 
1991). It was found that modification of the HSPG-binding domain of the protem severely 
decreased its biological activity (Heath et al., 1991). The biological significance of the 
interaction between bFGF and HSPGs is explained in vanous ways. First, bFGF may be 
stored in these bFGF-HSPG structures and metabolized when needed by remodelling of the 
basement membrane or extracellular matrix by hydrolases (Folkman et al., 1988; Vlodavsky 
et al., 1991). Second, bFGF-HSPG binding m endothelial cells prevents bFGF from being 
washed out by the blood. Furthermore HSPG will neutralize the positive charge of bFGF 
which increases the mobility and, thus, action of the protem (Flaumenhaft et al., 1990) 
Third, bFGF-HSPG binding is a prerequisite for binding to high-affinity FGF-receptors 
(Rapraeger et al., 1991; Yayon et al., 1991). Binding of extracellular bFGF to a high 
affinity receptor induces a mitogemc response through a protein-kinase С dependent 
intracellular signalling pathway (Presta et al., 1986). On the other hand, bindmg of 
intracellular bFGF to the plasma membrane induces a different, plasminogen activator 
inducing, pathway (Presta et al., 1989). Isacchi et al. (1991) showed that these two pathways 
are induced by different domains of bFGF. To date, four genes have been identified that 
each encode a distinct high affinity membrane-receptor for FGF (Ruta et al., 1988; Komblut 
et al., 1988; Pasquale, 1990; Partanen et al., 1991). Most of these genes encode multiple 
proteins through alternative splicing (Champion-Amaud et al, 1991; Crumley et al., 1991; 
Eisemann et al., 1991; Johnson et al., 1990; Johnson et al., 1991; Werner et al., 1992). 
The existence of a high affinity nuclear FGF-receptor is unknown (Dell'Era et al., 1991). 
The biological role of each of these different FGF-receptor proteins is unclear and 
complicated because FGF binding to a FGF-receptor induced transphosphorylation of other 
FGF-receptors present (Bellot et al., 1991). 
Involvement of bFGF in injury repair and smooth muscle cell proliferation 
bFGF can be synthesized by many cells types of the vascular system including endothelial 
cells and smooth muscle cells (Baird and Walicke, 1989; Klagsbrun and Edelman, 1989) 
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In vitro bFGF expression in endothelial cells and smooth muscle cells is well documented 
(Vlodavsky et al., 1987; Gospodarowicz et al., 1988). Tsuboi et al. (1990) described a 
positive correlation between the endogenous bFGF level and cell migration of endothelial 
cells. Addition of bFGF to cultures with a relatively low endogenous bFGF level and 
migration stimulated their rate of migration. 
In vivo, Lindner et al. (1991) showed the presence of bFGF in the carotid artery. 
Apparently, endothelial injury liberates this mitogen so that it can act on adjacent cells and 
initiate cell replication (Muthukrishnan et al., 1991). This observation emphasizes the 
significance of bFGF as a putative growth factor involved in repair of vascular lesions 
especially since endothelial cells release growth factors including FGF (Gajdusek and 
Carbon, 1989; McNeil et al., 1989). Lindner et al. (1989) observed that endothelial cell 
replication and the presence of extracellular bFGF were always associated. When replication 
ceased extracellular bFGF could not be detected anymore. Administration of bFGF after 
injury highly increased smooth muscle cell replication. In contrast, bFGF administration in 
arteries with an intact endothelium did not increase smooth muscle cell replication (Whalen 
et al., 1989; Lindner et al., 1991). bFGF addition also stimulated complete endothelial 
regrowth in situations where regrowth was severely limited (Lindner et al., 1990). These 
observations suggest an important role for bFGF in injury repair. However, bFGF release 
also stimulates smooth muscle cell proliferation which causes a significant increase in the 
growth of intimai lesions (Lindner et al., 1991). 
As described above, the influence of growth factors on the growth of smooth muscle cells 
in vivo is very complex due to the overwhelming number of different types of factors and 
effects. However, many of these effects seem to be generated by a modulation of the 
expression of bFGF and FGF-receptors. The major problem in interpreting these in vitro 
data is that smooth muscle cells in the adult artery hardly show any replication (Lombardi 
et al., 1991) in contrast to cultured smooth muscle cells. Therefore, it is important to study 
the ability of a growth factor to initiate mitosis in quiescent cells despite the technical 
difficulty to set up such a study. On the other hand, cell culture systems are very valuable 
for elucidating growth factor receptors, co-ligands and growth factor signalling pathways. 
Concluding remarks 
Evidence from vascular pathology together with epidemiologic data support the idea that 
atherosclerosis is a chronic, subclinical process. Only in the end of the process complications 
due to obstruction of the blood flow become manifest. Obviously, much more research is 
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needed on the pathogenesis of atherosclerosis. Very little is known on smooth muscle cell 
proliferation in vivo and even less about controls of smooth muscle replication in 
hypertension. Prolonged hypertension is associated with hypertrophy and polyploidy of 
smooth muscle cells in large vessels and with hyperplasia of these cells in small vessels. 
How these effects are caused is not yet known. The increased cell mass in the small vessels 
in its turn probably sustaines a chronic hypertension. Interactions in growth control between 
different cell types, mediated by a large number of growth factors, complicate our 
interpretation of data obtained from in vivo experiments. In vitro studies of a single cell type 
in culture provides us with a much less complex system although we have to keep in mind 
that the kind and level of growth factor(s) production in vivo may be very different from 
the situation in vivo. Furthermore, in sharp contrast with the situation in vitro, cells in the 
normal vessel wall hardly grow. Despite these drawbacks, in vitro growth data may provide 
a useful framework within which new directions for research may be developed. Because 
of the data reviewed above, FGF more than other growth factors, will probably emerge as 
a crucial, but certainly not exclusive, regulator of normal and pathological processes in the 
artery wall. 
Outline of this thesis 
In this thesis approaches to study aspects of growth in terms of gene expression in cultured 
rat aortic smooth muscle cells are presented. The rat is a very good model system for 
studying intimai thickening that in humans is considered to be the first step in the process 
ultimately leading to atherosclerotic plaques (Armstrong and Heistad, 1990). 
Our collaborators in Seattle observed unique properties for aortic smooth muscle cells from 
newborn rats, when compared to aortic smooth muscle cells from adult rats (Seifert et al., 
1984; Gordon et al., 1986). Interestingly, some of these properties also could be observed 
when neointimal smooth muscle cells of balloon injured adult rats were cultured suggesting 
that both cell types have proliferative capabilities (Schwartz et al., 1990a). 
We further investigated differences between these cell types. We studied the relationship 
between ploidy and gene expression for several genes in aortic smooth muscle cells derived 
from newborn and adult rats and show that the total amount of RNA in the cultures is linked 
with ploidy. However, expression of single genes only matched ploidy within a culture and 
not between newborn and adult cultures and likely reflects differences in their developmen-
tal state (Chapter 2). 
In Chapter 3 cultured aortic smooth muscle cells from adult and newborn rats were forced 
25 
to express the skeletal muscle gene MyoD, a DNA-binding protein. By doing so we ob­
served a differential effect induced by MyoD when bFGF is present. In Chapter 4 we further 
investigated this differential effect and showed that there are differences in expression of 
FGF-receptors in newborn versus adult cells. We also found differences in the expression 
of bFGF in these cells. 
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Abstract 
Aging and hypertension increase the number of polyploid smooth muscle cells 
(SMC) in a blood vessel. We assessed the effect of ploidy on the transcription of 
several genes in SMC cultures derived from newborn and adult rats. In diploid and 
tetraploid subcultures of SMC from newborn rats, RNA expression of the genes 
assayed is linked with ploidy. However, when phenotypically different SMC cultures 
derived from newborn and adult rats were compared, transcription levels varied 
from gene to gene, not linked with the ploidy. Thus, differences in gene expression 
due to polyploidy are superimposed on those due to other phenotypical features. 
Introduction 
Smooth muscle cell (SMC) proliferation is thought to play a major role in the 
development of both atherosclerosis and hypertension [1]. Velican and Velican [2] 
showed that SMC replication is the initial event in the formation of atherosclerotic 
plaques. 
Folkow et al. [3] implicated thickening of the vessel wall in established hypertension 
Abbreviations: FCM, flow cytometry; PBS, phosphate buffered saline; SMC, smooth muscle cell(s). 
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as an adaptation to the increased peripheral resistance. Typically, DNA synthesis in the 
aorta and other large blood vessels consists of DNA replication without cell division, 
resulting in the accumulation of polyploid cells that account for most of the increased 
mass of hypertensive vessels [4,5]. In agreement with those observations, Owens et al. 
[6] found a fixed ratio between protein and DNA content in vascular SMC of Wistar 
Kyoto rats and those of spontaneously hypertensive rats. Moreover, they noticed that 
polyploidy does not occur in SMC of pre-hypertensive spontaneously hypertensive rats. 
Polyploidization takes place after increase of blood pressure [7] and, once established, it 
is permanent. Reversal of hypertension failed to decrease the percentage of polyploid 
aortic SMC [8]. Only cell death is able to lower the DNA content. Therefore, 
antihypertensive therapy can prevent DNA ploidy increase only in an early stage [9]. 
Polyploidy is a normal change in several types of cells during the lifetime of animals 
[10] and humans [11]. It is also seen in certain types of cells in culture at late passage 
[12]. Despite the general occurrence of polyploidy, the tacit assumption that the 
expression of genes is proportional to the ploidy of a cell has never been verified. 
In this study, we show the relationship between ploidy and transcription of actin, 
platelet-derived growth factor A, collagen III and fibronectin in tetraploid and diploid late 
passage cultures of aortic SMC, isolated from newborn and adult rats respectively as well 
as in subcloned diploid and tetraploid cultures from newborn rats. Our results indicate a 
balanced relationship between ploidy and transcription levels in newborn SMC 
subcultures whereas the ratio between transcription levels in SMC derived from newborn 
and adult rats vary from gene to gene. These findings facilitate an interpretation of 
observed differences in gene expression in different phenotypes of vascular SMC. 
Materials and methods 
Cell culture 
Thoracic aortas from 12 day old (newborn) or 3 month old (adult) male Wistar Kyoto 
rats were removed. The tunica media was isolated and SMC were placed into culture as 
described [13]. SMC were grown in Waymouth's medium supplemented with 10% FBS 
(Hyclone, Logan, UT). To maximize the difference in ploidy between newborn and adult 
SMC, the cultures were used at very late passage (between the sixtieth and eightieth 
passage). Nearly pure diploid and tetraploid cultures of newborn SMC were obtained by 
growing cultures out of replated single cells in 96 well tissue culture plates (Costar, 
Badhoevedorp, The Netherlands) and were assayed by flow cytometry. 
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Flow cytometry 
Cultures to be studied were analyzed in the confluent state after a growth arrest for 
seven days in serum free Waymouths medium. After trypsinization, the cells were 
centrifuged at 1500 χ g for 5 min. The cell pellet was resuspended in ice-cold 70% 
ethanol and incubated at -20 0C for 12 h. The suspension was centrifuged at 1500 χ g 
for 5 min and the pellet was resuspended in 1 mM phosphate buffered saline (PBS) with 
20 μg/ml propidium iodide (Fluka, Brussels, Belgium) and 0.1 mg/ml RNase 
(Boehringer, Mannheim, FRG). The suspension was incubated for 1 h at room 
temperature and the lack of cell clumps was verified microscopically on the sample 
before being run on the flow cytometer. Chicken erythrocytes were used as an internal 
standard. The area of cell cycle compartments were estimated according to the method of 
Dean and Jett [14]. 
Chromosome counts 
Chromosome counts were performed as described by Lawce et al. [15]. 
RNA probes 
Antisense RNA probes were made using the Riboprobe Gemini System (Promega, 
Madison, WI) according to the manufacturers recommendations. The used DNAs were as 
follows: For aain, a 1.8 kb fl-actin cDNA isolated from a rat SMC cDNA library, 
cloned in pBluescript (Stratagene, Heidelberg, FRG). For smooth muscle a-actin, a 25 bp 
oligonucleotide (5' AGT GCT GTC CTC TTC TTC АСА CAT A 3'), nucleotides -6 to 
18 relatively to the coding region of the human smooth muscle a-actin gene kindly 
provided by Dr R. Meek (Department of Pathology, University of Washington, Seattle, 
WA, USA) [16]. For collagen HI, a 600 bp EcoRI - PvU Π fragment from rat collagen 
Ш clone RGR-5, cloned in pBluescribe (kindly donated by J.K. Mäkelä and E. Vuorio, 
University of Turku, Turku, Finland). For fibronectin, a 500 bp rat cDNA, cloned in 
pGEM2, kindly donated by С Giacelli (University of Washington, Seattle, WA, USA). 
For PDGF A, a 1000 bp cDNA isolated from a rat SMC cDNA library, cloned in 
pBluescript. 
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RNA-isolation and determination of total RNA 
Total cellular RNA was isolated by the lithium-urea procedure as described by Auffray 
and Rougeon [17]. Cell pellets of newborn and adult SMC and cell pellets of newborn 
clone 1 and clone 10 were processed together giving a reproducible yield by this method. 
The amount of total RNA per cell was determined as described by Merchant et al. 
[18], based on the measurement of the pentose content by the orcinol reaction. In brief: 
tissue culture cells were counted, pelleted and dounced. An aliquot was hydrolyzed in 0.3 
M КОН and incubated the mixture for 30 min at 95 0C in 5 volumes coloring reagent. 
The absorption at 665 nm was measured and compared to a yeast tRNA calibration 
curve. Coloring reagent: 0.18 g orcinol (Sigma, St. Louis, MO), 6 mg FeCl3 (Merck, 
Darmstadt, FRG) in 30 ml 35% HCl (Merck, Darmstadt, FRG). 
Solution hybridization 
Solution hybridization was executed as described by Lee and Costlow [19]. In brief: 
fixed amounts of 3 2P labelled antisense RNA were coprecipitated with increasing amounts 
of total RNA, isolated from 80% confluent SMC cultures. The total amount of RNA was 
adjusted to 100 μ% with yeast tRNA (Boehringer, Mannheim, FRG). After centrifugation 
the pellet was dried briefly, dissolved in 50% formamide, 0.4 M NaCl, 20 mM Pipes pH 
6.8 and 1 mM EDTA in a final volume of 20 μ\ and hybridized for 40 h at 60 "С. Sixty 
five μg RNase A and 150 U RNase Tl (Boehringer, Mannheim, FRG) were added and 
incubated at 37 "C for 1 hr. Protected RNA-duplexes were precipitated using 10% TCA, 
filtered through a Glasfaser Vorfilter (Schleicher and Schuell, Dassel, FRG) and the 
amount of protected antisense RNA probe was determined by counting in a liquid 
scintillation analyzer. Each experiment was repeated at least 3 times. Results were 
compared by Student's t-test and ρ = 0.05 or less was accepted as significant. 
DNA isolation 
Chromosomal DNA was isolated as follows: Cells, scraped in PBS, from a 150 cm2 
tissue culture flask (Costar, Cambridge, UK), were centrifuged for 5 min at 1500 χ g. 
The pellet was washed with PBS and dissolved in 10 ml 10 mM Tris-HCl pH 8.0, 1 mM 
EDTA (TE). 400 μΐ 5 M NaCl and 500 ці 10% sodium dodecyl sulphate were added and 
the cells were lysed at room temperature. Proteinase К (Boehringer, Mannheim, FRG) 
was added to a final concentration of 50 /tg/ml and incubated for 2 h at 37°С. After an 
extraction with TE-saturated phenol, the water phase was removed to a clean tube and 
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extracted with chloroform. The water phase was removed to a clean tube and 2.5 
volumes ethanol were added. The DNA was spooled, dried briefly and dissolved in 2 ml 
TE. 200 μg RNase were added and incubated for 20 min at 370C. 100 μΐ 10% sodium 
dodecyl sulphate and proteinase К to a final concentration of 50 itg/ml were added. After 
a phenol and chloroform extraction 2.5 volume 96% ethanol was added. The DNA was 
spooled, dried briefly and dissolved in 0.5 ml TE. 
Southern blotting 
Southern blots were made using Hybond N* (Amersham, 's Hertogenbosch, The 
Netherlands) following manufacturers recommendations and hybridized with 1-2 106 cpm 
per ml of 32P-labelled DNA probes according to the method described by Church and 
Gilbert [20]. Membranes were washed at 65 0 C in 0.1 M sodium phosphate pH 7.2, 1% 
SDS, 1 mM EDTA pH 8.0 for 2x 30 min. 
Densitometry 
Intensities of hybridization signals were quantified using a LKB Brumma 2202 
Ultrascan laser densitometer (LKB, Uppsala, Sweden) following manufacturers 
guidelines. 
Results and discussion 
Culture morphology 
Aortic SMC from three month old (adult) Wistar Kyoto rats in culture have a spindle 
shape morphology and grow in overlapping bundles organized in multilayers at 
confluence as described by Gordon et al. [13] (fig. la). In contrast, SMC of 12 day old 
(newborn) rats grow in a monolayer and have an endothelial-like morphology (fig. lb). 
Yet, they do contain mRNA coding for a-actin and lack Von Willebrand factor (results 
not shown), clearly indicating the SMC nature of these cells. a-Actin and Von 
Willebrand factor are established markers for SMC and endothelial cells respectively 
[13]. 
Mow cytometry 
Flow cytometry (FCM) revealed that 86% of the late passage adult SMC had a DNA 
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Morpholog> ot ral aortic SMC in varo \dult lal and newborn ibi rat aortic SMC were grown to confluence and photographed b\ 
phabe-contrast light microscopy. 
content corresponding to a diploid rat cell. 14% of the cells were tetraploid (figure 2a). 
Most of these cells are true tetraploid cells and not diploid cells in the G2 phase because 
3H-thymidine incorporation experiments indicate that less than 1% of the adult cells 
replicate after 1 week serum starvation (result not shown). FCM of late passage newborn 
SMC revealed that 15% of the cells were diploid, 66% tetraploid and 16% of the cells 
had a DNA content corresponding with an octaploid rat cell (fig. 2b). In stead of true 
tetraploid and octaploid cells, these cells could also be dividing diploid and tetraploid 
cells respectively. In order to obtain more homogeneous cultures of diploid and tetraploid 
newborn SMC, we subcloned the initial culture of newborn SMC, replating out cells at 
an average cell density of 1 cell per well. Thus we obtained an almost pure diploid 
(clone 1) and tetraploid (clone 10) newborn SMC subculture, as assayed by FCM (fig. 2c 
and 2d, respectively). 
Table i 
Chromosome counts on mctaphase spreads ot aortic SMC in cultures of adult and newborn rats 
SMC culture Percentage ol spreaib in cluster Total number ol spreads 
Diploid"1 Tetraploid" Octaploid 
\dult 42 8 47 
Newborn · 89 37 
Newborn clone I 89 5 38 
Newborn clone 10 91 34 
Metaphase spreads were made and assased as descnoed in Materials and Methods 
"The diploid (^ 42 chromosomesi cluster consistei] ol counts in the 39 45 chromosomes range 
The tetraploid cluster consisted ot counts in the "s-90 chromosomes range 
The octaploid cluster consisted ot counts in the 1ςί>-18() chromosomes range 
a) 
b) 
i n ita !М ты 
Г ig 2 How cviometrvtf-CMlofcloned populalionsol smooth muscle cells (a) Adult SMC culture showing Xb^r 2C and М г^ 4C (mcludimz diploid 
cells in the 02 phase) cells (b) Newborn SMC culture showing 1 51 2C ЬбГ^  4C (including diploid cells in the CJ2 pha^el and 16^ КС (includinu 
tciraploid cells in the G2 phase) (cl Diploid newborn SMC subclone (clone 11 showineWv 2C and «'T- 4C (including diploid сеііып the 02 phase ι 
(dl Tetraploid newborn SMC subclone (clone 10) showing 929c 4C and ÍCí SC (including tetraploid cells in ihe 02 phase! Ploid^ was determined 
using chicken ervthroc\tes as an internal standard The experiments were carried out in 2 sets a - b is one set с - d is another set 
Chromosome counts 
Chromosome counts were performed on metaphase spreads of the four rat aortic SMC 
cultures. In general, the chromosome counts fit our FCM data for the different cultures 
(table I). Diploid and tetraploid spreads were clearly present but with some dispersion in 
the actual counts, caused by errors when counting many very small rat chromosomes. 
Since chromosomes are easily lost or rearranged in long term tissue culture, relative 
copy numbers of the genes used for measuring transcription prevalence were determined. 
Southern blots containing equal amounts of EcoRI digested chromosomal DNA were 
hybridized with DNA probes for actin, collagen III, fibronectin and PDGF A. 
Densitometrie scanning of the autoradiogram revealed equal intensities in all lanes, 
indicating a linear relationship between the hybridization signal intensities and the amount 
of DNA used (results not shown). This observation, together with FCM analysis and 
chromosome counts, indicates that the gene dose of the genes included in this study is 
directly proportional to the ploidy of a particular culture of SMC. 
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Quaniitdtion of (he lotal amount 
itdult and 
SMC cultures Ploidv 
:c 
Adult 86 
Newborn 15 
Newborn clone 1 92 
Newborn clone 1Ü 
of RNA 
newborn 
percentage 
4C 
14 
66 
8 
9 : 
per cell 
rais 
οι cells 
SC 
16 
8 
in SMC cultúrese· 
pe RN A cell' 
26 ζ 5 
< 6 z 10 
^8 ί 4 
58 ΐ : 
Total RNA was isolated from 10B cells as desenbed in Materials and 
Methods The ploid> percentage ol the cultures was determined b\ 
flow cylometrv 
* Values represent mean of 3 separate experiments perlormed in dupl·-
cate 
Quantitation of transcription of several genes in adult and newborn SMC does not 
match ploidy 
In each of the SMC cultures the amount of total RNA was determined using a 
quantitative RNA-isolation procedure (see Materials and Methods). It appeared that the 
amount of total RNA per SMC matched the ploidy of the cell; in tetraploid cultures, cells 
contained about twofold more RNA than diploid cultures did (table II). To quantitate 
transcription levels of single genes in 
Т а Ы е
 " the newborn and adult cultures, 
solution hybridization assays were 
conducted using a panel of genes (fig. 
3). Our results show that the ratio of 
transcription in newborn and adult 
SMC varies from gene to gene and 
does not depend on gene doses 
(ploidy) alone. Therefore, we conclude 
from the experiments specified below 
that newborn and adult SMC represent 
clearly distinct phenotypes. 
Actin expression is raised significantly in newborn SMC (fig. 3a). Newborn cells 
contain three fold more actin transcripts than do adult cells. Corrected for ploidy, that is 
a 1.5 fold relative overexpression in newborn SMC. Due to the high homology amongst 
members of the actin gene family, the ß-actin probe used, hybridized to all actin 
transcripts giving no information about smooth muscle specific a-actin expression solely. 
However, Northern analysis with a SMC a-actin specific oligonucleotide suggests that 
this differentiation marker is more abundant in adult SMC, again indicating that these 
newborn and adult SMC represent different phenotypes (result not shown). On the other 
hand solution hybridizations to RNA from the diploid newborn SMC subclone (clone 1) 
and the tetraploid newborn SMC subclone (clone 10) show that in these cells, for all 
genes assayed, the transcription level is linked with ploidy (fig. 4). Therefore, the 
observed difference in actin gene expression must be viewed as a difference between 
newborn and adult SMC rather than a difference between diploid and tetraploid SMC. 
Clearly, the expression of actin genes in newborn and adult SMC is controlled in a 
different manner. 
The solution hybridization experiments show a ploidy dependent expression of collagen 
ΙΠ mRNA in adult and newborn SMC (fig. 3b). The expression in the newborn subclones 
also is ploidy dependent (fig. 4b). Collagen Ш is a component of both the normal vessel 
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actin 
• 1000 cpn hyD<idii»a 
4 · 1 
microgram total RNA 
C ) PDGF-A 
• tOOO cpm hrbnduad 
20 so 40 ao 
microgram total RNA 
collagen 
• юоо com Hybrid uta 
« 20 24 28 32 36 40 44 
mtc'ogram total RNA 
d) fibronectin 
ι ЮОО cpm hybrldilftd 
« io гв 
microgram total RNA 
~ш~п~ ~».. - ^ n « b * n ~ · Λ « Ι 
I a î Solunon h\bridi/aiion dssa\ οι varioustranscnpi^ in newborn and aüuii S\IC cultures Total RNA was isolated as destnbcd in Materials 
nd Methods and h\bridi/cd in solution lo the Tollowing probes and contentraiions la) ^-ai-lin 4 ng lb) collaeen I I I I ng lei platelet-derived 
-riiwih lactor \ ') И ne and Idi hbroneain 1 пг ι I fcxpenmcnis лиЬ t e a l RNA Irom newborn smooth muscle cells (--) Fxperimcnts »uh 
total RNA Irom adult smooth muscle cells f o r otner details sec Materials and Methods 
wall and the atherosclerotic plaque in which no significant raise in the amount of 
collagen III is observed [21]. 
PDGF A is expressed 4 fold higher in newborn SMC than it is in adult SMC (fig. 3c). 
Since an adult SMC contains half the amount of DNA compared to a newborn SMC, this 
reflects a 2 fold raise in transcriptional activity per gene copy. In solution hybridizations 
to RNA from newborn SMC clone 1 and clone 10 the transcription level correlates with 
ploidy (fig. 4c). PDGF A is a mitogen for cultured SMC [22]. In the vascular system 
PDGF A expressing cells were found in the inuma where endothelial cells and neointimal 
SMC showed PDGF A expression. Medial SMC did not express PDGF A [23]. Majesky 
et al. [24] hybridized Northern blots with equal amounts of RNA isolated from newborn 
and adult SMC cultures, using a probe for PDGF A. They showed an equal hybridization 
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isolated as 
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rn smooth 
d Methods 
intensity in both lanes. It is unknown whether the difference in amount of mRNA we 
observe, is related to the late passage number of the cultures or, more likely, reflects the 
better accuracy of the solution hybridization technique. 
Fibronectin expression correlates with ploidy (fig. 3d). On a per cell basis, newborn 
SMC contain two fold more fibronectin mRNA than adult SMC do. Fibronectin 
expression in clone 1 and clone 10 also matches ploidy (fig. 4d). Fibronectins are large 
glycoproteins that play a role in many biological processes including cellular adhesion, 
morphology and cytoskeletal organization [25]. 
All together these results indicate a different control of gene expression in cultures of 
SMC derived from newborn and adult rats, not strictly linked with ploidy. Neonatal 
SMC in culture are able to produce the peptide growth factors required for their own 
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growth [26]. The reduced expression of the genes coding for contractile proteins suggest 
that neonatal SMC, compared to adult SMC, represent a lesser differentiated SMC [27]. 
The phenotype of newborn SMC is also seen when neointimal SMC are brought in 
culture [28] or when adult SMC are cultured in platelet-deprived serum [29]. These 
observations suggest that the coat of a blood vessel may be heterogeneous, containing 
SMC with different functions and phenotypes [30]. Less differentiated SMC could serve 
as stem cell population maintaining the regenerative potential whereas differentiated SMC 
control the contractile properties of a blood vessel. The newborn and adult SMC culture 
system provides a useful tool for studying these differences that are relevant to the 
development of atherosclerosis and hypertension. 
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Abstract 
MyoD is a master regulatory gene for myogenesis that also converts many mesoderm 
derived cells into the skeletal muscle phenotype. Rat aortic smooth muscle cells do not 
contain MyoD homologous mRNA. However, expression of an exogenously supplied 
MyoD gene in aortic SMC cultured from newborn and adult animals converts these 
cells to elongated myoblasts and myotubes expressing the skeletal muscle genes for titin, 
nebulin, myosin and skeletal or-actin. 
The presence of bFGF during growth and serum starvation completely inhibits 
MyoD-mediated conversion in cultures of newborn SMC. However, in SMC cultures 
derived from adult rats the presence of bFGF increases the conversion frequency. 
The differential response on exogenous MyoD suggests that the two morphological 
types of aortic smooth muscle cells, one typical for the newborn rat, the other for the 
adult rat, represent two distinctive states of differentiation. 
55 
Introduction 
A variety of data, in vivo and in vitro, suggest that smooth muscle cells (SMC) from the 
newborn aorta may differ from SMC of the adult aorta (Schwartz et al., 1990b). These 
studies also suggest that the aorta of adult animals consists either of cells able to recapitulate 
this earlier developmental state (Campbell et al., 1988) or contains a subset of immature 
SMC capable of replicating and differentiating in response to injury (Schwartz et al., 1986). 
Deciding between these two ideas: "modulation" of one cell between two phenotypes and 
amplification of subsets is difficult. Since we lack firm evidence that the newborn-derived 
cell seen in cell culture has the potential to differentiate into an adult cell, the two cell types 
could be as different from one another as myoblasts are from the satellite cells that give rise 
to these myoblasts able to form skeletal muscle myotubes. Approaching this issue, however, 
is difficult because we do not have an in vitro system as well defined as those used to study 
skeletal muscle differentiation. Both newborn and adult SMC express smooth muscle a-actin, 
the best characterized marker for this lineage that, however, also can be expressed in 
fibroblasts under specific conditions such as wound healing (Kocher et al., 1985; Darby et 
al., 1990). While a number of other markers have been defined for SMC in vivo (e.g. 
smooth muscle myosin (Hammerle et al., 1988), meta-vinculin (Glukhova et al., 1986) and 
a smooth muscle specific caldesmon (Sobue and Sellers, 1991)), little is known about how 
the expression of these genes is controlled in smooth muscle in in vitro systems. 
Cultured SMC derived from the aorta of newborn rats differ from cultured SMC from the 
aorta of adult rats in morphology (Gordon et al., 1986), growth characteristics (Seifert et 
al., 1984) and gene expression (Majesky et al., 1988: Giachelli et al., 1991). Moreover, 
differences between newborn and adult aortic smooth muscle also can be seen in vivo, 
suggesting that these distinctions are inherent to the cell rather than influenced by other 
extrinsic controls of cell phenotype. The differences in Wvo include the smaller numbers of 
newborn SMC expressing some of the proteins seen in adult SMC (Kocher et al., 1985; 
Kocher and Gabbiani, 1986: Majesky et al., 1988; Glukhova et al., 1990). The most impres-
sive difference for the same cells in vitro is in growth control. SMC derived from the 
newborn aorta, in contrast to SMC derived from the adult aorta, do not require platelet 
derived mitogens and, in fact, constitutively secrete mitogens (Seifert et al., 1984). SMC 
from the adult aorta forming the neointima after balloon angioplasty show a phenotype very 
similar to the cells cultured from the newborn wall (Walker et al., 1986; Schwartz et al., 
1990a). Again these cultured cells grow in medium prepared without platelet release and 
secrete growth factors. Moreover, in vivo, the neointima has an extensive proliferative 
response that persists differentiation for months after injury (Majesky et al., in press). 
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In contrast to our lack of knowledge of the control of differentiation in smooth muscle, a 
great deal is known about skeletal muscle differentiation at the level of control of 
transcription. Davis et al. (1987) identified a gene product, MyoD, that was characteristic 
of myoblasts even when these cells were not differentiated into myocytes or myotubes. 
MyoD containing myoblasts will differentiate into skeletal muscle if appropriate growth 
factors are removed from the medium. MyoD thus marks and determines the skeletal muscle 
lineage. This protein belongs to family of homologous helix-loop-helix proteins (Weintraub 
et al., 1991). MyoD is apparently the last gene necessary to convert 10T1/2 cells to a 
myoblast lineage, suggesting that these cells express other, as yet unidentified, cis- or 
trans-acting factors that determine the muscle phenotype (Weintraub et al., 1991). Since 
many of the proteins seen in the smooth muscle cell are also expressed in precursors of 
skeletal muscle (Emerson and Berstein, 1987; Otey et al., 1987) it is reasonable to think that 
skeletal muscle cell precursors may share elements that control expression of lineage specific 
markers. The experiments described here were designed to explore the function of MyoD 
in newborn and adult smooth muscle. We report that neither smooth muscle type expresses 
MyoD. However, there is a marked difference in the percentage of cells converted to 
skeletal muscle when MyoD is introduced into the two cell types. Under appropriate 
conditions, MyoD causes massive conversion of the adult cell to skeletal muscle. These cells 
express much of the striated muscle phenotype but have not lost expression of such smooth 
muscle markers as smooth muscle a-actin. In contrast, under these same conditions, 
newborn cells do not convert. Our data suggest that the differences between newborn and 
adult SMC may be related to differences seen in the developmental precursors of striated 
muscle. 
Materials and Methods 
Cell Culture 
Thoracic aortas from 12 day old (newborn) or 3 month old (adult) male Wistar rats were 
removed. The tunica media was isolated and SMC were placed into culture as described 
(Gordon et al., 1986). SMC were grown in Waymouth's medium supplemented with 10% 
FBS (Hyclone, Logan UT, U.S.A.) and were used between the fifteenth and twentieth 
passage. 
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Retroviral Infection 
MDSN, a MyoD cDNA containing retrovirus and LNL-6, the parental retrovirus, lacking 
the MyoD insert, were generously provided by Dr A.D. Miller (Fred Hutchingson Cancer 
Research Center, Seattle, WA, U.S.A.). Both MDSN and LNL-6 are constructed from an 
amphotropic retrovirus in which a neomycin phosphotransferase gene is transcribed from an 
internal SV-40 early promoter enhancer (Bender et al., 1987) enabling selection of infected 
cells with the neomycin-analog G418 (Gibco, Paisley, Scotland). MyoD is expressed from 
the viral long terminal repeat (Weintraub et al., 1989). SMC were plated in 60 mm petri 
dishes (Costar, Cambridge, UK) at a density of 30,000 cells/cm2 and allowed to settle for 
24 h. Then the medium was removed and replaced with medium containing 4 μΐ/ml 
polybrene (Sigma, St. Louis, MO, U.S.A.) and 100 μί viral stock (titer: 107 neomycin-
resistant colony-forming units per ml). After 16 h the medium was changed, G418 (300 
μg/ml) and, in the cases indicated, 10 ng/ml basic fibroblast growth factor (bFGF) 
(Promega, Madison, WI, U.S.A.) were added. The cells were passaged and grown to 80% 
confluency, i.e. 80% of the surface of the tissue culture dish was covered with cells. Then 
the medium was changed to serum free Waymouths medium for 7 days which initiates 
conversion. 
Immunostaining 
SMC were grown on glass microscopic slides until they reached 80% confluency. Then 
the medium was changed and the cells were serum starved as described above. In order to 
immunostain for skeletal muscle specific proteins the cells were rinsed 3 times in PBS, 
incubated 2 min in 70% ethanol, 3.7% formaldehyde, 5% glacial acetic acid (for assays 
using peroxidase conjugated secondary antibodies) or by dipping the glass microscopic 
slides in cold methanol for 3 s, followed by acetone fixation, for immunofluorescence 
experiments and air dried at room temperature. 
Fixed SMC were incubated with the following antibodies: Against myosin: a mouse anti-
chicken myosin heavy chain monoclonal antibody, MF-20 (Bader et al., 1982) which was 
a kind gift of Dr S.D. Hauschka (Dept. of Biochemistry, University of Washington, Seattle, 
WA, U.S.A.). This antibody reacts with all sarcomenc myosins. Against titin: a polyclonal 
antiserum to titin isolated from chicken gizzard (Gassner, 1986) which was a kind gift of 
Dr D. Gassner (University of Bonn, Bonn, FRG). Against titin: a mouse monoclonal 
antiserum (9D10) (Wang and Greaser, 1985), and against sarcomenc tropomyosin: a mouse 
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monoclonal antiserum (CH-1) (Lin et al., 1985), both obtained from the Developmental 
Studies Hybridoma Bank, maintained by the Department of Pharmacology and Molecular 
Sciences, John Hopkins University School of Medicine, Baltimore, MD, U.S.A. and the 
Department of Biology, University of Iowa, Iowa City, IA, U.S.A. under contract N01-
HD-6-2915 from the NICHD. Against nebulin: a mouse monoclonal antibody NB2 (Sigma, 
St. Louis, MO, U.S.A.). Against desmin: a mouse monoclonal antibody D3 (Danto and 
Fishman, 1984) a kind gift of Dr D. A. Fishman (Department of Cell Biology and Anatomy, 
Cornell University Medical College, New York, NY, U.S.A.). Against Von Willebrand 
factor, a mouse monoclonal antibody, A082 (Dakopatts, Denmark) (Sehested and Hou-
Jensen, 1981). Against smooth muscle a-actin: a mouse monoclonal antibody 1A4 (Sigma, 
St. Louis MO, U.S.A.). 
The cells were incubated with the primary antibody for 30 min at room temperature. They 
were rinsed in PBS, and when double labelling was performed incubated with a second 
antiserum. After washing with PBS, they were incubated with the appropriate anti-mouse 
or anti-rabbit immunoglobulins, conjugated with peroxidase, fluorescein isothiocyanate (both 
from Nordic, Tilburg, The Netherlands) or Texas-Red (Southern Biotechnology Associates, 
Birmingham, AL, U.S.A.). After rinsing with PBS the cells were mounted in GELVATOL 
(Monsanto, St. Louis, MO, U.S.A.) or proceeded for the detection of peroxidase by rinsing 
in 50 mM Tris pH 7.5, 10 mM imidazole and incubating in 50 mM Tris pH 7.5, 10 mM 
imidazole, 0.05 % diamino benzidine (DAKO, Glostnip, Denmark), 0.025 % hydrogen 
peroxide for 30 - 45 min. The reaction was stopped by rinsing in 50 mM Tris pH 7.5, 10 
mM imidazole. 
DNA-auíoradiography 
SMC were grown on glass microscopic slides until they reached 80% confluency. Then 
the medium was changed and the cells were serum starved as described above. Waymouth's 
medium supplemented with 10% FBS and 1 μΰί/πϋ 3H-methyl thymidine (Amersham, 's 
Hertogenbosch, The Netherlands) was added for 12 h. Then the medium was removed and 
the cells were washed with PBS and immunostained for sarcomeric myosin as described 
above. The slides then were dipped in Kodak NTB2 filmemulsion. Autoradiography took 
place for 4 weeks. Subsequently the slides were developped in Kodak D19 développer and 
fixed in 24 % sodium thiosulphate. the cells were contra stained in haematoxylin, dehydrated 
in graded ethanol concentrations and xylene and mounted in synthetic resin. 
59 
RNA-isolation 
Total cellular RNA was isolated by the lithium-urea procedure as described by Auffray and 
Rougeon (1980). 
Northern blot Analysis 
Glyoxylated-RNA samples were electrophoresed through 1 % agarose gels submerged in 10 
mM sodium phosphate pH 7.2 (Maniatis et al., 1982); transferred to a nylon membrane 
(HYBOND N, Amersham, UK) and hybridized with 1-2 χ IO6 cpm per ml of I2P-labelled 
DNA probes according to the method described by Church and Gilbert (1984). Membranes 
were washed twice at 650C in 0.1 M sodium phosphate pH 7.2, 1% SDS, 1 mM EDTA pH 
8.0 for 30 min. 
Blot hybridization with 3 2P 5'-terminal labelled oligonucleotides were executed in 5 χ 
Denhardt's mix, 0.5% SDS, 6 χ SSC, 100 μg/ml denatured salmon sperm DNA, 0.05% 
sodium pyrophosphate at 45 0C. Membranes were washed twice at 42CC in 0.2 χ SSC, 
0.1% SDS for 20 min. 
Hybridizations with the inosine oligonucleotide DL27 (see below) were executed using the 
hybridization mix described by Church and Gilbert (1984) at temperatures between 420C and 
Ъ20С. The filters were washed in 40 mM sodium phosphate pH 7.2, 1% SDS, 0.05% BSA 
and 1 mM EDTA, at a temperature 8 "С below the hybridization temperature. 
DNA Probes 
DNA probes used for Northern blot-hybridization analysis were as follows: for MyoD, a 
mouse 1.8 kb cDNA probe, kindly provided by Dr A. B. Lassar (Fred Hutchingson Cancer 
Research Center, Seattle, WA, U.S.A.) Pavis et al., 1987). For MyoD low stringency 
hybridizations, a 38 bp degenerated MyoD inosine-oligonucleotide DL27 (5' ATG TA(G/C) 
I(G/C)G ITG GCI Ш П(0/С) AGG АТС ICI ACC TTI GG 3'), kindly donated by Dr H. 
Weintraub (Fred Hutchingson Cancer Research Center, Seattle, WA, U.S.A.). For desmin, 
a 0.8 kb hamster desmin cDNA kindly provided by Dr H. Bloemendal of our laboratory 
(Quax et al., 1985). For myosin a human 0.5 kb adult myosin light chain 2 cDNA kindly 
provided by Dr В. Nadal Ginard (Department of Pediatrics, Harvard Medical School, Boston 
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MA, U.S.A.) (Garfmkel et al., 1982). For troponin, a 0.5 kb fragment of the mouse fast 
troponin I cDNA clone сМПЗа, kindly provided by Dr К. Hastings (Neurological Institute, 
University Montréal Québec, Canada) (Koppe et al., 1989). For cardiac muscle a-actin, a 
40 bp oligonucleotide (5' CTG ATG GGA GAT GGG AGA GGG CCT С AG AGG ATT 
CCA AGC A 3') representing part of the rat cardiac a-actin 3' untranslated region, and for 
skeletal muscle a-actin, a 40 bp oligonucleotide (5ΆΑΤ СТА TGT АСА CGT CAA AAA 
CAG GCG CCG GCT GCA GTG G 3') representing part of the rat skeletal a-actin 3' 
untranslated region, both kindly provided by Dr R. Schwartz (Department of Cell Biology, 
Baylor College of Medicine, Houston, TX, U.S.A.). For smooth muscle a-actin, a 25 bp 
oligonucleotide (5' AGT GCT GTC CTC TTC TTC АСА CAT A 3"), nucleotides -8 to 18 
relatively to the coding region of the human smooth muscle a-actin gene kindly provided 
by Dr R. Meek of our laboratory (Ueyama et al., 1984). 
Results 
Throughout this paper, to avoid the repeated use of long descriptions, we will use the terms 
'adult SMC' and 'newborn SMC' for cultures of smooth muscle cells derived from aortae 
of, respectively, 3 month old or 12 days old rats. 
No MyoD Homologue is Detectable in SMC 
Cultured adult SMC have a spindle shape morphology and grow in overlapping bundles 
organized in multilayers at confluence (Gordon et al., 1986). In contrast, cultured newborn 
SMC grow in a monolayer fashion and have an endothelial-like morphology. These newborn 
cells express the smooth muscle marker a-actin (Gordon et al., 1986) but do not express von 
Willebrand factor (Sehested and Hou-Jensen, 1981) an established endothelial cell marker 
(results not shown). 
In order to search for MyoD homologous transcripts, we screened Northern blots, containing 
equal amounts of total RNA from cultures of newborn and adult SMC with an inosine 
containing MyoD consensus oligonucleotide under low-stringency conditions (Martin and 
61 
Castro, 1985). Rat skeletal muscle control RNA showed a single hybridization signal (fig. 
la). No specific hybridization signal was detectable in RNA samples isolated from rat aortae 
(fig. lb) and cultured adult and newborn SMC (fig. 1 с and d respectively). 
MyoD Converts Newborn and Adult SMC to Myosin-positive Cells at an Equal Percentage 
Cultures of newborn and adult SMC were infected with a MyoD containing amphotropic 
retrovirus (MDSN) or the MyoD-lacking parental retrovirus (LNL-6), both containing the 
neomycin phosphotransferase gene. After 
G418 selection, the cells were grown to 
80% confluency, placed in serum-free 
medium and immunostained for sarcomeric 
myosin. About 2% of the MDSN infected 
newborn (fig. la) and adult SMC (fig. lb) 
stained positive for skeletal myosin. 
Morphologically these converted cells were 
elongated and resembled postmitotic 
myoblasts. In the LNL-6 controls no 
sarcomeric myosin positive cells were 
detected (fig. 2c and 2d). 
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selectively Converts Adult SMC. 
Fig. 1. Northern analysis of MyoD expression 
in rat skeletal and smooth muscle. Total RNA 
from rat tissues and cell cultures was isolated, 
analysed by Northern blotting (30 ^g total 
RNA per lane) by hybridization to "P 5'-ter 
minai labelled MyoD inosine oligonucleotide 
(see Materials and Methods): (A) leg muscle; 
(5) total aortic; (Q cultured adult SMC; 
(D) cultured newborn SMC. 
at the start of the G418 selection, completely 
We explored the effects of basic fibroblast 
growth factor (bFGF) on this system 
because of evidence that this mitogen plays 
a role in myoblast differentiation. bFGF 
is known to inhibit myotube formation in 
myoblasts (Vaidya et al., 1989) although 
in Xenopus embryos, bFGF plays an 
important role in the induction of 
mesoderm formation (Amayaetal., 1991). 
Continuous presence of bFGF, beginning 
inhibited conversion in newborn SMC even 
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when serum was withdrawn (fig. 3a). In adult SMC, on the other hand, the presence of 
bFGF raised the percentage of converted cells seen upon withdrawal of serum. 
The adult cultures showed cells positive for sarcomeric myosin. These cells were grouped 
in bundles in which complete fusion was seen. Depending on the experiment, 10-30% of the 
nuclei present in the culture were found in these myotubes (fig. 3b). Other cells expressed 
sarcomeric myosin but did not fuse (fig. 3c and 3d). If we count these nuclei as well as 
those in myotubes in converted adult cells, grown in the presence of bFGF, the overall 
percentage of nuclei seen in myosin positive cells was 20 - 50%. In the LNL-6 controls no 
converted cells were detectable (results not shown). 
S 
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Fig. 2. Conversion of cultured newborn and adult aortic SMC by MyoD. Newborn (a and c) and 
adult φ and d) SMC were infected with a MyoD containing retrovirus MDSN (a and b), or with 
the parental retrovirus LNL-6 (c and d). Neomycin expressing cells were selected with G418 and 
serum starved for 7 days followed by immunostaining for sarcomeric myosin (see Materials and 
Methods). 
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bFGF had to be given immediately after infection in order to see the enhancement of 
conversion. Presence of bFGF during serum starvation only, does not increase the amount 
of converted cells compared to cells not treated with bFGF (result not shown). It is 
intriguing to observe that not all cells in the dish convert although all cells are G418 
resistant and thus must express the neomycin phosphotransferase and MyoD genes (see 
Materials and Methods). 
Since true skeletal muscle cells become post-replicative when they differentiate, we examined 
the ability of converted SMC to replicate. We converted an adult SMC culture, previously 
grown and serum starved in the presence of bFGF. Serum was re-added and after 24 hours 
Fig. 3. Conversion by MyoD of cultured newborn and adult aortic SMC grown in the presence 
of bFGF. MDSN-infected newborn (a) and adult ф, с, d) SMC were grown and serum starved 
for seven days continuously in the presence of 10 ng/ml bFGF. The cultures were immunostained 
for sarcomeric myosin. Different morphologies seen in the adult SMC are shown ф, c, d). 
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the converted culture was grown for twelve hours in the presence of Η-thymidine. The 
culture then was stained for sarcomeric myosin and analyzed by autoradiography. About ten 
percent of the cells were stained positive for sarcomeric myosin and none of these cells 
incorporated 3H-thymidine in their nucleus. Almost all cells that stained negative for 
sarcomeric myosin did incorporate 3H-thymidine (fig. 4). These observations suggest that 
cultured adult SMC contain a subpopulation of cells that are convertible under the direction 
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Fig. 4. Replication of converted 
MDSN-infected adult SMC. MDSN-
infected adult SMC were grown 
on coverslips and serum starved 
for seven days. The culture was 
refed with serum containing 
medium in the presence of 3H-
thymidine for twelve hours. 
The culture then was immuno-
stained for sarcomeric myosin 
and analyzed by autoradiography 
as described in Materials and 
Methods. 
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Fig. 5. Northern blot analysis of 
MyoD transcripts in cultures of 
uninfected and MDSN-infected 
newborn and adult aortic SMC. 
Newborn (N), MDSN-infected 
newborn (IN), adult (A) and 
MDSN-infected adult (IA) SMC 
were treated as described in the 
legend to fig. 2- Total-RNA was 
isolated and a Northern blot was 
prepared and screened with "P-
labelled MyoD cDNA. The 
positions and sizes of the phage 
λ Hindlll marker fragments are 
indicated. 
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of MyoD and once converted by removal of serum undergo terminal differentiation and are 
no longer capable of replication. The majority of the cells, on the other hand do not convert 
and retain their capability to grow in culture. 
AduU SMC, Converted in the Presence ofbFGF, Transcribe many Skeletal Muscle Genes 
To determine the status of the myogenic differentiation program of converted SMC, MDSN-
infected cultures of newborn and adult SMC grown with and without bFGF, were serum 
starved and total RNA was isolated. Transcription of the viral encoded MyoD was, as 
expected, exclusively linked with MDSN-infection. Activauon of the endogenous MyoD gene 
was not seen in these cells (fig. 5), since expression of the endogenous gene should lead to 
a hybridization signal of 2.5 kb (fig. la). 
Expression of a number of skeletal muscle genes was assayed on Northern blots containing 
equal amounts of total RNA from MDSN-infected convened newborn and MDSN-infected 
converted adult SMC cultures, RNA from serum starved MDSN-infected newborn SMC 
grown in the presence of bFGF (without detectable conversion) and RNA from MDSN-
infected adult SMC grown in the continuous presence of bFGF (with a high conversion 
percentage). Northern blot analysis of the cells using myosm light chain 2 cDNA as a probe 
showed a hybridization signal in the bFGF-treated MDSN-infected adult SMC (fig. 6a), 
corresponding to a mRNA size of 0.9 kb as expected (Garfmkel et al., 1982). Expression 
in bFGF-treated MDSN-infected adult SMC but not in MDSN-infected newborn and MDSN-
infected adult SMC and bFGF-treated MDSN-infected newborn RNA was a consistent 
pattern for several skeletal muscle markers, with hybridization signals corresponding to 
mRNAs of the expected size (see references in section "Materials and Methods"), was seen 
for skeletal muscle a-actin (fig. 6b) and troponin (fig 6c). In contrast, expression of cardiac 
muscle a-actin was not observed (results not shown). 
To examine the possibility that MyoD also influences the level of expression of genes 
normally expressed in SMC we assayed expression of smooth muscle a-actin and desmin. 
Desmin is of particular interest because this gene is expressed in both skeletal muscle cells 
and in smooth muscle cells. Therefore, we hybridized the corresponding cDNA probes to 
Northern blots of MDSN-infected and uninfected newborn and adult SMC. The level of 
expression of the SMC a-actin gene is unaffected by the presence of MyoD (fig. 7). The 
expression pattern of desmin is not clear. In some cultures the presence of MyoD seems to 
upregulate the transcription of the desmin gene as shown by the increased intensity of the 
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2.1 kb hybridization signal (fig. 8). In other cultures desmin transcription is very low and 
seems to be unaffected by MyoD or can not be detected irrespective the presence of MyoD. 
The reason for this variability remains unclear. It is, however, of interest to note that these 
results at the RNA level contradict the common experience that cultured SMC lose desmin 
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Fig. 6. Northern blot analysis of expression of genes coding for skeletal muscle contractile 
proteins in cultures of MDSN-infected newborn and adult aortic SMC maintained and converted 
in the presence or absence of bFGF. MDSN-infected SMC were maintained and serum starved in 
the absence (marked IN and IA for MDSN-infected newborn and adult SMC respectively) or 
presence of 10 ng/ml bFGF (marked INF and IAF for MDSN-infected newborn and adult SMC 
repectively). Total RNA was isolated and a Northern blot was made and hybridized with a "P-
labelled myosin light chain 2 cDNA (a), a skeletal a-actin oligonucleotide (b) and a skeletal 
muscle specific fast troponin I cDNA (c). The positions and sizes of the phage λ Hindlll marker 
fragments are indicated. 
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as seen by immunocytochemistry or by Western blotting (Campbell et al., 1989). We 
confirmed this in immunocytochemical studies (results not shown). 
The detection of RNA for various skeletal muscle genes in MDSN-infected adult SMC 
treated with bFGF suggests a conversion into the skeletal muscle phenotype. We were 
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Fig. 7. Northern blot analysis 
of smooth muscle a-actin trans­
cripts in uninfected and MDSN-
infected cultures of newborn 
and adult aortic SMC. Cultures 
of newborn (N), adult (A), 
MDSN-infected newborn (IN) 
and MDSN-infected adult (IA) 
SMC were serum starved for 7 
days. Total RNA was isolated 
and a Northern blot was hybrid­
ized with a 32P-!abelled smooth 
muscle a-actin oligonucleotide. 
The positions and sizes of the 
phage λ Hindill marker 
fragments are indicated. 
Fig. 8. Northern analysis of 
desmin transcripts in uninfected 
and MDSN-infected cultures of 
newborn and adult aortic SMC. 
Cultures of Newborn (N), 
Adult (A), MDSN-infected 
Newborn (IN) and MDSN-
infected Adult (IA) SMC were 
serum starved for 7 days. Total 
RNA was isolated and a Northern 
blot, containing 50 μg total RNA 
per lane, was hybridized with 
52P-labelled desmin cDNA. The 
positions and sizes of the phage 
λ HindIII marker fragments are 
indicated. 
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unable to detect the transcription of skeletal muscle genes in MDSN-infected SMC grown 
in the absence of bFGF probably because of the low number of converted cells in these 
cultures. This question can be assessed by immunostainings using antibodies to the 
corresponding proteins (see below). 
Converted SMC Express many Myofibrillar Proteins 
Cultures of newborn and adult SMC, infected with MDSN and converted, were stained for 
various skeletal muscle myofibrillar or intermediate filament proteins to determine whether 
the myogenic conversion included a spectrum of skeletal muscle proteins and, as noted, to 
characterize the small frequency of cells that convert when bFGF is absent (fig. 9). As 
shown before, the presence of bFGF during growth and conversion influences the percentage 
of conversion to the skeletal muscle phenotype. However, irrespective of the presence of 
bFGF in the culture medium all converted cells express the skeletal muscle genes assayed 
(result not shown). Immunostaining for sarcomeric tropomyosin (fig. 9a), myosin (fig. 9b), 
titin (fig. 9c), nebulin (fig. 9d) and desmin (fig. 9e) showed the characteristic banding 
pattern for these proteins. These data indicate that MyoD activates the complete myogenic 
differentiation program in these SMC cultures including infected, converted cells grown in 
the absence of bFGF. No expression of these skeletal muscle proteins, however, could be 
found in uninfected SMC or in newborn SMC infected with the virus and grown and serum 
starved in the presence of bFGF (results not shown). 
Fig. 10. Double-stained elongated myoblasts from converted cultures of MDSN-infected newborn 
and adult aortic SMC. MDSN-infected SMC were seeded on coverslips. The cells were 
converted, fixed on the glass and double-stained for smooth muscle α-actin (a) and titin (b), with 
the use of fluorescein-labelled secondary antibodies. 
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Fig. 9. Representative elongated myoblasts from different convened SMC cultures immunostained 
for various sarcomeric proteins and desmin. MDSN-infected newborn and adult SMC were 
seeded on coverslips. The cells were converted, fixed on the glass and immunostained for striated 
muscle tropomyosin (a), myosin (b), titin (c), nebulin (d) and desmin (e) with the use of a 
fluorescein-labelled secondary antibody. 
70 
To investigate the expression of SMC-specific proteins in converted cells, converted SMC 
were double stained for titin and for the smooth muscle specific form of α-actin. Single 
converted SMC express smooth muscle α-actin (fig lOa) and titin (fig. 10ft)· These data 
show that MyoD expression is sufficient to activate the myogenic program in SMC without 
repressing expression of SMC a-actm. 
Discussion 
The observations presented here show that retrovirally mediated MyoD expression is able 
to induce differentiation steps m cultured aortic SMC that normally occur in the skeletal 
muscle lineage. This is consistent with the earlier report of Choi et al. (1990) of striated 
muscle conversion after transfection of cultured gizzard SMC. This is an artefactual 
expenment since, unlike skeletal muscle cells, SMC lack MyoD or any other closely related 
protein able to explain the patterns of gene expression used to identify smooth muscle cells 
as belonging to a single cell type. The observed absence of endogenous MyoD expression 
in arterial smooth muscle is in agreement with the results reported by Braun et al. (1989) 
Vrho were unable to detect expression of MyoD in human uterus. In addition, Hopwood et 
al (1989) showed that expression of MyoD in embryos of Xenopus is solely linked with 
skeletal muscle formation. It is important to realize that MyoD, by itself, is not sufficient 
to induce complete expression of the skeletal muscle phenotype As with the original 
observations in 10T1/2 mouse fibroblasts, the presence of MyoD in rat aortic SMC does not 
result in the expression of the muscle phenotype unless serum, and thus growth factors, are 
withdrawn. Therefore, the ability of MyoD to control the phenotype of these cells must also 
depend on additional factors, some of which are related to the absence of serum. Our data 
suggest that the ability of MyoD to convert aortic smooth muscle to the skeletal muscle 
lineage also appears to depend on the SMC's state of development. 
SMC obtained from the arterial media of newborn rats or from the neointima formed after 
balloon injury of adult rats, when placed into culture, grow independently of platelet-
denved factors and display a characteristic epitheloid monolayer growth. In contrast, SMC 
cultured from the arterial media of adult rats display the typical spindle shaped 'hill and 
valley' growth pattern (Schwartz et al., 1990a). Furthermore, both newborn SMC and 
neointimal SMC express a number of genes that are not expressed in adult SMC (Giachelh 
et al., 1991; Majesky et al., in press). Because these expression patterns are stable m 
passaged cells, they presumably represent changes in differentiation rather than reversible 
changes m function such as the changes in expression of contractile proteins as seen during 
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modulation (Campbell et al., 1988). 
Newborn and adult SMC differ in their response to MyoD when exogenous bFGF is present. 
In newborn SMC MyoD converts 2% of the cells, but the conversion is inhibited by bFGF. 
Adult SMC also show 2% myogenic conversion in the absence of bFGF and 2 0 - 5 0 % 
conversion in the presence of bFGF. It should be noted that, independent of the age of the 
rats or the presence of bFGF, conversion always includes the formation of elongated 
myoblasts, myotubes and the expression of many skeletal muscle genes (figures 5 and 8). 
It should also be noted that all cells in these experiments, converted as well as non-
converted cells, express only the exogenous MyoD gene because neomycin selection was 
imposed to the cultures after infection with the retroviral construct. Neither uninfected nor 
infected SMC expressed the endogenous MyoD gene (fig. 5). Thayer et al. (1989) described 
the expression of endogenous MyoD mRNA by transfection with a MyoD cDNA in 10T1/2 
and Swiss 3T6 cells but not in several other fibroblast cell lines. This suggested that other 
factors need to be present in order to activate the endogenous MyoD gene. Similarly, the 
data suggest, at least in the presence of FGF, that adult and newborn SMC differ in the 
expression of molecules that control the cells' ability to respond to MyoD. 
Even within the adult cell population, the response to MyoD is not uniform. We have shown 
that the susceptibility to conversion by exogenous MyoD occurs in a distinct subset within 
the population of cultured SMC, since non-converted cells, after propagation in the presence 
of the neomycin-analog G418, do not convert at a later stage (fig. 4). This diversity of 
response is consistent with other evidence that the vessel wall contains a mixture of SMC 
phenotypes (Babaev et al., 1990; Zanellato et al., 1990) and with evidence for stable 
morphologic differences between clones of SMC (Dreher and Cowan, 1991; Hall et al., 
1991). 
We do not have a satisfactory explanation for the ability of bFGF to influence the 
differentiation of these cells. The mechanism by which bFGF influences conversion into 
myoblasts and myotubes is unknown. Spizz et al. (1986) showed that bFGF completely 
blocks conversion of myoblasts at concentrations at least tenfold lower than that required 
for mitogenic activity. During the terminal differentiation of skeletal muscle FGF-receptors 
are lost (Olwin et al., 1988). Vaidya et al. (1989) report that bFGF inhibits expression of 
MyoD in myoblast cultures. Such a mechanism is clearly not operative after infection of 
cells with the viral construct MDSN in which the MyoD gene is not directed by authentic 
regulatory elements. Perhaps, under the direction of MyoD, a subset of highly convertible 
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adult SMC become bFGF dependent, whereas they have been grown in the absense of bFGF 
during many passages prior to infection. Addition of bFGF right after infection enables these 
cells to survive, giving rise to a high percentage of conversion to the skeletal muscle 
phenotype. A similar subset of FGF-dependent chick embryo myoblasts was described by 
Seed and Hauschka (1988). Additional experiments are needed to clarify this point. 
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Abstract 
Cultured smooth muscle cells from aortae of newborn and adult rats differ in 
several cell biological properties. Here we report the differential effect of basic 
fibroblast growth factor (bFGF) as well as of the master regulatory gene of 
myogenesis, MyoD (expressed in these cells after infection with a retroviral 
construct), on a number of parameters (DNA synthesis, conversion to the skeletal 
muscle phenotype, bFGF mRNA synthesis, expression of FGF-receptor genes). We 
show that cells from adult animals, in contrast to those from newborn animals, are 
more sensitive to bFGF. bFGF stimulates their conversion by MyoD, and it triggers 
its own mRNA synthesis. Moreover, the level of the 4.2 kb transcript of the Fig 
gene (coding for the most abundant FGF-receptor in smooth muscle cells) is higher 
in smooth muscle cells from adult rats. In constrast the FGFR-Ъ gene is only 
expressed in smooth muscle cells from newborn rats. 
When the transcription of other FGF-receptor genes (bek and FGFR-4) was 
studied Northern analyses indicated the existence of still other FGF-receptor 
variants not yet described in the literature. 
Cross linking of [1zsI]bFGF to its receptor showed 130 kD and 160 kD complexes. 
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Introduction 
Cultured SMC derived from the aorta of newborn rats differ from cultured SMC from 
the aorta of adult rats in morphology (Gordon et al., 1986), growth characteristics 
(Seifert et al., 1984) and gene expression (Majesky et al., 1988: Giachelli et al., 1991). 
Moreover, differences between newborn and adult aortic smooth muscle also can be seen 
in vivo, suggesting that these distinctions are inherent to the cell rather than influenced 
by other extrinsic controls of cell phenotype. The differences in \ivo include the smaller 
numbers of newborn SMC expressing some of the proteins seen in adult SMC (Kocher et 
al., 1985; Kocher and Gabbiani, 1986: Majesky et al., 1988; Glukhova et al., 1990). 
The most impressive difference for the same cells in vitro is in growth control. SMC 
derived from the newborn aorta, in contrast to SMC derived from the adult aorta, do not 
require platelet derived mitogens and, in fact, constitutively secrete mitogens (Seifert et 
al., 1984). SMC from the adult aorta forming the neointima after balloon angioplasty 
show a phenotype very similar to the cells cultured from the newborn wall (Walker et 
al., 1986; Schwartz et al., 1990). Again these cultured cells grow in medium prepared 
without platelet release and secrete growth factors. Moreover, in vivo, the neointima has 
an extensive proliferative response that persists differentiation for months after injury 
(Majesky et al., in press). 
To gain more insight in these differences we brought these two types of SMC under 
the regime of the master regulatory protein MyoD (van Neck et al., submitted). MyoD 
belongs to a family of helix-loop-helix proteins and commits many cells of mesodermal 
origin, including SMC, to enter the myoblast lineage (Weintraub et al., 1991; Choi et 
al., 1990). Conversion of "newborn SMC by MyoD is blocked by basic fibroblast 
growth factor (bFGF). In contrast, in "adult SMC" bFGF highly increased the percentage 
of cells convertible by MyoD (van Neck et al, submitted). 
Clarifying the role of bFGF in the vascular system is of importance to an 
understanding of atherosclerosis since bFGF is an important mitogen in the blood vessel 
wall. bFGF is synthesized in endothelial cells, SMC and macrophages in vitro (Klagsbrun 
& Edelman, 1989). In vivo, Lindner et al. (1991) showed the presence of bFGF in the 
carotid artery. Administration of bFGF after vascular injury highly increased smooth 
muscle cell replication. In contrast, bFGF administration in arteries with an intact 
endothelium did not increase smooth muscle cell replication (Lindner et a!., 1991). bFGF 
addition in injured arteries also stimulated complete endothelial regrowth in situations 
where regrowth was severely limited (Lindner et al., 1990). These observations suggest 
an important role for bFGF in injury repair and SMC proliferation, ultimately leading to 
the formation of the neointima (Lindner & Reidy, 1991). 
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bFGF is a member of a family of seven structurally related polypeptides characterized 
by their high affinity to heparin (Rifkin & Moscatelli, 1989; Vlodavsky et al, 1991). 
bFGF affects many biological events including cell growth, differentiation and 
embryogenesis and is highly angiogenic (Burgess & Maciag, 1989). Its biological effects 
are mediated by high affinity cell surface receptors (FGFRs) belonging to the protein 
tyrosine kinase family. Four different FGFRs have been cloned so far: Fig (Ruta et al., 
1988), bek (Kombluth et al, 1988), Cek-2 (Pasquale, 1990) and FGFÄ-4 (Partanen et 
al, 1991). FGFRs share structural features including a tyrosine kinase domain split by a 
short insert and an extracellular region consisting of multiple glycosylated 
immunoglobulin-like domains (Ig-like domains) and a hydrophobic leader sequence 
(Ullrich & Schlessenger, 1990). 
In the present study we report that SMC derived from aortae of newborn and adult 
rats, have a different response to bFGF. Subsequently, we describe the expression of 
fibroblast growth factor receptors (FGFRs) in these types of SMC. 
Materials and Methods 
Cell culture 
Thoracic aortas from 12 day old (newborn) or 3 month old (adult) male Wistar rats were 
removed. The tunica media was isolated and SMC were placed into culture as described 
(Gordon et al, 1986). SMC were grown in Waymouth's medium supplemented with 10 
% FBS (Hyclone, Logan, UT, USA), 2 mM glutamine, 100 u/ml penicillin, 100 u/ml 
streptomycin (all from Gibco, Paisley, Scotland) and were used between the fifteenth and 
twentieth passage. 
Retroviral infection 
MDSN, a MyoD cDNA containing retrovirus was generously provided by Dr A.D. 
Miller (Fred Hutchinson Cancer Research Center, Seattle, WA, USA). MDSN is 
constructed from an amphotropic retrovirus in which a neomycin phosphotransferase gene 
is transcribed from an internal SV-40 early promoter enhancer (Bender et al, 1987) 
enabling selection of infected cells with the neomycin-analog G418 (Gibco, Paisley, 
Scotland). MyoD is expressed from the viral long terminal repeat (Weintraub et al, 
1989). SMC were plated in 60 mm petri dishes (Costar, Cambridge, UK) at a density of 
30,000 cells/cm2 and allowed to settle for 24 h. Then the medium was removed and 
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replaced with medium containing 4 μΐ/ml polybrene (Sigma, Deisenhofen, Germany) and 
100 μΐ viral stock (titer: 107 neomycin-resistant colony-forming units per ml). After 16 h 
the medium was changed and G418 (300 /ig/ml) was added. In the cases indicated, 1 
ng/ml or 10 ng/ml basic bFGF (Promega, Madison, WI, USA) or 1:50 diluted polyclonal 
anti-bFGF (ΒΉ, Stoughton, MA, USA) was added at 80 % confluency, i.e. 80 % of the 
surface of the tissue culture dish was covered with cells. 
DNA replication assays 
[methyl-3H] Thymidine (Amersham, 's Hertogenbosch, The Netherlands) was added to 
the cell culture media at a final concentration of 1 juCi/ml and incubated for 2 h at 37 
"С. Then the medium was removed and the cells were washed with phosphate buffered 
saline (PBS). DNA was precipitated on the dish with cold 10% trichloracetic acid. 
Precipitates were dissolved in 0.3 M NaOH and the amount of incorporated 3H-methyl 
thymidine was determined by counting in a liquid scintillation analyzer. 
RNA-isolations 
Total cellular RNA was isolated by the lithium-urea procedure as described by Auffray & 
Rougeon (1980). 
Northern blot analysis 
Glyoxylated-RNA samples were electrophoresed through 1% agarose gels submerged in 
10 mM sodium phosphate pH 7.2 (Maniatis et al., 1982); transferred to a nylon 
membrane (Hybond N, Amersham, 's Hertogenbosch, The Netherlands) and hybridized 
with 1-2 106 cpm per ml of 32P-labelled DNA probes according to the method described 
by Church & Gilbert (1984). Membranes were washed twice at 650C in 0.1 M sodium 
phosphate pH 7.2, 1 % SDS, 1 mM EDTA pH 8.0 for 30 min. In order to assay other 
probes on the same blot in one case probes were stripped of the blot by washing in 0.1 
% SDS at 95 0C. 
DNA probes 
DNA probes used for Northern blot hybridization analysis were as follows: For bFGF, 
plasmid pJJl-1, a pBR322 derivative containing a 1.4 kb insert derived from the bovine 
bFGF gene (Abraham et al., 1986). For Fig: clone pCD115 contains the entire 
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extracellular domain of the human Fig cDNA, cloned into pGEMl (Dionne et al., 1990). 
For bek: pGC34 is a 860 bp human partial bek cDNA clone coding for the 5' 
untranslated region through the first Ig-like domain loop, cloned into pGEM-1. Clone 
pCD116 contains the entire extracellular domain of the human bek cDNA, cloned into 
pGEMl (Dionne et al., 1990). Век 16A/17B is a 144 bp tefc-exon specific fragment 
obtained by PCR of human genomic DNA with the primers bek 16A (GCC GCC GGT 
GTT AAC ACC ACG GAC) and bek 17B (TGG CAG AAC TGT CAA CCA TGC 
AGA) (Dionne et al., 1990). For K-sam: K-sam 3A/4B is a 147 bp K-sam exon specific 
fragment obtained by PCR of human genomic DNA with the primers K-sam ЗА (TTG 
CTG ITT TGG CAG GAC AGT GAG) and K-sam 4B (CAC TCG GGG ATA AAT 
AGT TCC AAT) (Hattori et al., 1990). For FGFR-3: a 820 bp SstI fragment from clone 
JTK4 coding for the tyrosine kinase domain (Partanen et al., 1991). For FGFR-4: a 1 kb 
EcoRI fragment from clone JTK2 coding for the extracellular domain (Partanen et al., 
1990). The latter two probes kindly were provided by Dr. K. Alitalo (Dept. of Virology 
and Pathology, University of Helsinki, Helsinki, Finland). 
Antibodies 
Against bFGF, a rabbit polyclonal antiserum (ΒΉ, Stoughton, MA, U.S.A.). Against 
Fig, rabbit polyclonal antisera, znú-Flg EC-2, raised against bacterially expressed Fig 
extracellular domain. Against bek, rabbit polyclonal antisera, znú-bek EC-1, raised 
against bacterially expressed bek extracellular domain and bek 1С, raised against the 
terminal 17 amino acids of the human bek protein. 
Protein isolations 
Total protein was isolated as described by Kleid et al. (1981). 
Immunoprecipitations 
Cells at 90 % confluence, grown in 10 cm tissue culture dishes were washed three times 
with PBS and scraped in 0.5 ml of lysis buffer (20 mM Hepes pH 7.5, 150 mM NaCl, 
10 % glycerol, 1 % Triton X-100, 1.5 mM MgCl2, 1 mM EDTA, 1 /tg/ml aprotinin, 1 
μ%/πυ leupeptin, 1 mM phenylmethylsulfonyl fluoride) and incubated for 15 min on ice. 
The lysates were centrifuged for 15 min in an Eppendorf centrifuge at 4 "С. Three mg 
of protein A-Sepharose (Pharmacia, Uppsala, Sweden) per sample was swollen and 
washed with 20 mM Hepes pH 7.5 and then mixed for 30 min at room temperature with 
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normal rabbit serum. The lysates were incubated for 60 min at room temperature and 
centrifuged for 15 min in an Eppendorf centrifuge. Three mg of protein A-Sepharose 
(Pharmacia, Uppsala, Sweden) per sample was swollen and washed with 20 mM Hepes 
pH 7.5 and then mixed for 30 min at room temperature with the corresponding rabbit 
anti-peptide antisera followed by three washes with 20 mM Hepes pH 7.5, 150 mM 
NaCl, 0.1 % Triton X-100, 10 % glycerol. The protein A-Sepharose/antibody complexes 
were then incubated with the pre-treated clarified cell lysates for 60 min in 20 mM 
Hepes pH 7.5, 150 mM NaCl, 0.1 % Triton X-100, 10 % glycerol at 4 0 C, washed 
twice with 50 mM Hepes pH 8.0, 500 mM NaCl, 0.2 % Triton X-100 and 5 mM 
EDTA, twice with 50 mM Hepes pH 8.0, 150 mM NaCl, 0.1 % Triton X-100, 5 mM 
EDTA and 0.1 % SDS and finally twice with 10 mM Tris-HCl pH 8.0 and 0.1 % Triton 
X-100. Laemli sample buffer was added to the washed immunoprecipitates which were 
then boiled for 4 min and subjected to 7.5 % SDS-PAGE (Laemli, 1970). 
Autoradiograms of the dried gels were made. 
Binding of i2SI bFGF to SMC 
Binding of 1 2 5 I bFGF and unlabelled bFGF to subconfluent newborn and adult SMC was 
performed in 100 mm dishes. The cells were rinsed twice with 20 mM Hepes pH 7.2, 
130 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 3 mM KCl, 1 mg/ml BSA. The cells were 
preincubated for 10 min at 4 "С in 2 ml binding buffer before 20 ng 1 2 5 I bFGF (specific 
activity 4.2 10e cpm^g) was added. Subsequently, the cells were incubated for 3 h at 4 
"C in a rotary shaker oscillating at 50 cycles/min. Binding assays were terminated by 
rapidly rinsing the cultures 3 times in binding buffer. Non-specific binding was 
determined in the presence of a 100-fold molar excess of bFGF. For crosslinking bFGF 
to its receptor, 1 ml of PBS was added followed by 5 μΐ 0.05 M Bis(sulfosuccinimidyl) 
suberate (Pierce, Oud Beyerland, The Netherlands) in PBS. The cells then were 
incubated for 15 min at room temperature and washed once with binding buffer/ 2M 
NaCl. Then the cells were rinsed 2 times with PBS and 1 time with anti-protease buffer 
(1 mM EDTA, 1 mM phenylmethanesulfonyl fluoride, 1 /¿g/ml leupeptin, 1 μg/ml 
pepstatin A and 20 u/ml aprotinin). The cells were collected by scraping in 0.5 ml of the 
anti-protease buffer, rinsed one time with 0.5 ml of this buffer and centrifuged at 12,000 
χ g for 5 min. Membrane associated proteins were extracted in 30 μΐ anti-protease buffer 
containing 1% Triton X-100, at 4 ' C for 30 min. After centrifugaüng at 12,000 χ g for 
5 min the Triton XlOO-soluble and Triton XlOO-insoluble fractions were subjected to 7.5 
% SDS-PAGE (Laemli, 1970) and exposed after drying the gel. 
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Results 
Throughout this paper, to avoid the repeated use of long descnpuons, we will use the 
terms 'adult SMC' and 'newborn SMC' for cultures of smooth muscle cells derived from 
aortae of, respectively, 3 month old and 12 days old rats. Such cultures are called 
'infected' after infection with the retroviral construct MDSN which cames a MyoD gene 
as well as a neomycin resistance gene (Weintraub et al., 1989). Infected cultures were 
subjected to neomycin selection and were previously shown to consist of cells that indeed 
express the exogenously added MyoD gene (van Neck et ai, submitted). 
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Figure 1 Effect of bFGF on DNA replication in newborn 
and adult rat SMC. Adult and newborn SMC were plated 
at low density and allowed to grow to confluence. The 
cells then were serum starved for 7 days. Anti-bFGF and 
bFGF were added as indicated. 22 h after bFGF addition 
DNA replication was determined (see "Materials and 
Methods"). Bars indicate the standard error of three 
experiments. 
Growth stimulation of smooth 
muscle cells by bFGF 
Adult SMC have a spindle 
shape morphology and grow 
in overlapping bundles 
organized in multilayers at 
confluence (Gordon et al., 
1986). In contrast, newborn 
SMC grow in a monolayer 
fashion and have an 
endothelial-like morphology. 
These newborn cells express 
smooth muscle a-actin 
(Gordon et al., 1986) but we 
could not detect the 
expression of von Willebrand 
factor (results not shown), an 
established endothelial cell 
marker (Sehested & Hou-
Jensen, 1981). We investigated the effect of bFGF on DNA replication in these cultures 
(Figure 1). After addition of 10 ng/ml bFGF, DNA synthesis in serum-starved adult 
SMC was approximately seven times higher. The addition of anti-bFGF to adult SMC 
completely inhibited the stimulatory effect of bFGF. 
Addition of 10 ng/ml bFGF to serum-starved newborn SMC stimulated replication less 
than 2 fold (Figure 1). Addition of anti-bFGF only slightly reduced replication. Basal 
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replication in serum-starved newborn SMC was, compared to adult SMC, about 10 fold 
higher (Figure 1). In newborn SMC serum starvation reduced the replication rate only 
about 5 fold. In adult SMC serum starvation reduced the replication rate at 
least 50 fold (results not shown). Anti-bFGF, able to neutralize 10 ngr/ml bFGF in adult 
cells, had no effect on the high levels of replication in serum starved pup cells. 
Growth stimulation by bFGF of MDSN-infected smooth muscle cells 
x 1000 cpm Incorporit i 
X 
• 
i 
We previously showed that bFGF completely blocks conversion in infected newborn 
SMC but not in infected adult SMC (van Neck et al., submitted). We investigated the 
effect of bFGF in these cultures. bFGF was added to infected newborn and infected adult 
SMC and 3H-thymidine 
incorporation was measured. 
The results obtained were 
comparable with the 
replication stimulation by 
bFGF in uninfected SMC: 
replication of adult SMC was 
stimulated about 7 fold, 
whereas bFGF added to 
newborn SMC did not show 
much stimulation due to the 
high basal replication of these 
cells (Figure 2). Addition of 
anti-bFGF to infected SMC 
suppressed the stimulative 
effect of bFGF on replication. 
We also examined the effect 
of bFGF addition on the 
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Figure 2 Effect of bFGF on DNA replication in cultured 
newborn and adult rat aortic SMC expressing MyoD after 
infection with a MyoD containing retrovirus (MDSN). 
MDSN-infected adult and MDSN-infected newborn SMC 
cultures were analysed as described in the legend to 
Figure 1. 
endogenous synthesis of bFGF mRNA. Infected and uninfected newborn and adult SMC 
were treated with bFGF for 8 h, followed by the isolation of RNA. Northern blot 
analysis, with a bFGF-specific probe, showed no hybridization signal in newborn SMC 
and infected newborn SMC (Figure 3). RNA from uninfected and infected adult SMC 
showed a weak hybridization signal, corresponding with a mRNA of approximately 6 kb. 
bFGF addition to adult SMC (infected or not) induced a substantial increase in the 
amount of bFGF mRNA. A similar induction did not take place in newborn SMC. 
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Expression of FGFRs in cultured smooth muscle cells 
RNA from infected and uninfected newborn and adult SMC was isolated and Northern 
blots, with equal amounts of RNA in each lane as visualized directly on the blot, were 
hybridized with specific cDNA probes under hybridization conditions that prevent cross 
hybridization of the different receptors. Hybridization with pCD115, a cDNA 
representing the extracellular region of Fig demonstrated the presence of a 4.2 kb mRNA 
in all cultures assayed (Figure 4a). Densitometrie scanning of the Northern blot revealed 
that the amount of Fig mRNA in uninfected adult SMC is four times higher compared to 
that in the other SMC cultures. 
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Figure 3 Effect of bFGF on the expression of the bFGF gene in MDSN-infected and uninfected 
newborn and adult SMC. Newborn SMC (N), MDSN-infected newborn SMC (IN), adult SMC 
(A) and MDSN-infected adult SMC (IA) were plated at low density and allowed to grow. At 
80% confluency in the indicated cases 10 ng/ml bFGF was present for 8 h (8hF). Total RNA was 
isolated and analysed by Northern blotting (40 μg total RNA per lane) by hybridization to 3ZP-
labelled bFGF cDNA. The blot was submitted to autoradiography for 14 days. The positions and 
sizes of the λ HindIII marker fragments are indicated. 
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Figure 4 Transcription of bFGF-receptor genes in MDSN-infected and uninfected newborn and 
adult SMC. Newborn SMC (N), MDSN-infected newborn SMC (IN), adult SMC (A) and 
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MDSN-infected adult SMC (IA) were plated at low density and allowed to grow. At 80% 
confluency RNA was isolated and Northern blots were made, containing 40 μg total RNA per 
lane (a) or 10 μg polyA* RNA per lane (b,c,d). Northern blots were hybridized with 3 P-
labelled cDNA clones coding for parts ot the different FGF-receptors The specific regions of the 
FGF-receptors are indicated schematically and include a signal sequence (black box), 
immunoglobulin-like domains (Ι, Π and ΠΙ), a transmembrane domain (TM), tyrosin kinase 
domains (boxes) and a kinase insert (Ю). Horizontal bars indicate regions represented by probes. 
These probes were: (a) Fig pCD115, (b) bek pCD116, (c) FGFR-Ъ, (d) FGFRA The positions 
and sizes of the λ Hindlll marker fragments are indicated. 
Век expression in these cultures is very low. Hybridization with pCD116, a cDNA 
probe containing the sequence of the entire extracellular region of bek, on Northern blots 
containing 10 μ% poly A+ RNA, demonstrated the presence of a 4.5 kb mRNA in all 
SMC cultures (Figure 4b). Furthermore, a faint hybridization signal of about 6 kb was 
detected in all lanes. In RNAs from infected newborn and infected adult RNA a 
hybridization signal of about 4.2 kb was observed (Figure 4¿>). Hybridization with 
pGC34, a bek cDNA containing the sequence of the hydrophobic leader and the first Ig-
like domain, only demonstrated the presence of the 4.5 kb mRNA in all SMC cultures 
(result not shown). 
When the Northern blots were hybridized with a cDNA probe for FGFR-3, the human 
homologue of Cek-2 (Keegan et al., 1991) a 4.2 kb hybridization signal was detected in 
newborn and infected-newborn SMC (Figure 4c). Adult and infected-adult SMC did not 
show a hybridization signal. Hybridization with a cDNA probe for FGFRA showed a 1.7 
kb hybridization signal in uninfected and infected newborn and adult SMC after a seven 
day exposure of the Northern blot (Figure 4d). 
The bek premessenger codes for two proteins: bek and K-sam ( Champion-Amaud et 
al., 1991). Both mRNAs contain the same exon coding for the first half of the third Ig-
like domain and different exons coding for the alternative second halves of this domain 
specific either to bek or K-sam (Champion-Amaud et al., 1991). Therefore, we stripped 
off the probes from the poly A+ RNA blots and rehybridized the filters with a fragment 
of the bek specific exon. We detected a hybridization signal corresponding with a mRNA 
of about 4.5 kb in RNA from infected adult SMC. RNA isolated from newborn, infected 
newborn and adult SMC did not show any hybridization signal (Figure 5a). Hybridization 
with a fragment of the K-sam exon also only showed a hybridization signal in infected 
adult SMC corresponding with a mRNA of about 4.5 kb (Figure 5b). In summary, in all 
four SMC cultures a 4.2 kb and a 4.5 kb transcript were recognized by probes 
representing the leader sequence and the Ig-like domains of respectively Fig and bek. The 
latter probe also detected a 4.2 kb hybridization signal in cultures expressing MyoD. 
Intnguingly, a bek exon and K-sam exon specific probe only detected a 4.5 kb 
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hybridization signal in infected adult SMC. All four SMC cultures showed an expression 
signal with the FGFR-A probe. FGFR-3 transcripts only could be detected in newborn and 
infected-newborn SMC. 
Chemical cross-linking of fi^I] bFGF to cultured smooth muscle cells 
We analysed the binding of [125I] bFGF to infected and uninfected newborn and adult 
SMC. Following incubation of the cells with [125I] bFGF, receptor-bFGF complexes 
were covalently cross-linked, solubilized and subjected to SDS-PAGE and 
autoradiography (Figure 6). In all lanes an approximately 160 kD and an approximately 
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Figure S Expression of bek and K-sam mRNA in MDSN-infected and uninfected newborn and 
adult SMC. Newborn SMC (N), MDSN-infected newborn SMC (IN), adult SMC (A) and 
MDSN-infected adult SMC (IA) were cultured as described under Figure 4. Probes were stripped 
of from the poly A* RNA-blots shown in Figure 4 and re-hybridized with 3 P-labelled PCR 
fragments coding for parts of the bek (a) and K-sam (b) specific exons (see Materials and 
Methods). The specific regions of the FGF-receptors and the λ HindIII marker fragments are 
indicated as in Figure 4. 
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130 kD band were cross-linked. After subtracting the molecular weight of the ligand (± 
15 kD) the size of the cross-linked bands is 145 kD and 115 kD respecuvely. 
Expression of bek and Fig in cultured smooth muscle cells 
The translation products of Fig and bek were analysed by preparing cell extracts and 
immunoprecipitating with Fig- or bek-speciñc anti-peptide antisera. The 
Α ΙΑ N IN N IN A IA 
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200- ' . 
KD 
!06-
200-
116-
97-
Figure 6 Cross-linking of 
[1ÄI]bFGF to MDSN-infected 
and uninfected newborn and 
adult SMC. [125I]bFGF was 
covalentíy cross-linked to 
adult SMC (A), MDSN-infected 
adult SMC (IA), newborn SMC 
(N) and MDSN-infected new-
born SMC (IN) as described in 
Materials & Methods. The cells 
then were lysed, subjected to 
SDS-PAGE and the dried gel was 
exposed to X-ray film. The 
resulting autoradiogram is shown. 
The positions of the molecular 
weight standards are indicated. 
80-
Figure 7 Analysis of i7g-encoded 
protein by immunoprecipitation 
from MDSN-infected and unin-
fected newborn and adult SMC. 
Cultured newborn SMC (N), 
MDSN-infected newborn SMC 
(IN),adult SMC (A) and MDSN-
infected adult SMC (IA) were 
grown to almost confluency. The 
cells were lysed and the lysate 
was subjected to immunoprecipi-
tation analysis with anti-peptide 
antisera generated against Fig. 
The positions of the molecular 
weight standards are indicated. 
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immunoprecipitates were subjected to SDS-PAGE, followed by autoradiography. A band 
of approximately 145 kD and faint bands of 90 kD, 94 kD and 106 kD were specifically 
immunoprecipitated in both infected and uninfected newborn and adult SMC cultures with 
апй-Flg and-peptide antisera (Figure 7). Likely due to the low expression of the bek 
gene we were not able to specifically immunoprecipitate bands when using bek anti­
peptide antisera. The deduced amino acid sequence of Fig predicts a mature core protein 
of 89.4 kD (Dionne et al., 1990). Glycosylation at potential sites in the extracellular 
domain could account for the bands of higher molecular weights as seen in the figure. 
Discussion 
We previously described that rat aortic SMC cultures did not contain mRNA 
homologous to the master regulatory gene MyoD (van Neck et ai, submitted). However, 
in newborn and adult SMC a small percentage of the cells convert to the skeletal muscle 
phenotype when they are infected with MDSN, a MyoD cDNA containing retrovirus, and 
when the serum is taken away from the tissue culture medium. In the presence of bFGF, 
cultures of infected newborn SMC did not convert whereas about 30 - 50 % of the adult 
SMC were converted to the skeletal muscle phenotype (van Neck et al., submitted). In 
an attempt to understand these differences we studied the effect of bFGF and the 
presence of FGFRs in cultures of infected and uninfected newborn and adult SMC. 
Newborn and adult SMC grow equally well in culture. In serum starved cultures adult 
SMC almost stop growing while newborn SMC continue to grow at a reduced rate. This 
may be explained by autocrine stimulation of growth of newborn SMC but not of adult 
SMC (Seifert et al., 1984). In agreement with this observation bFGF has a much larger 
stimulatory- effect on the growth of serum starved adult SMC than it does on the actively 
growing newborn cells. This stimulation can be inhibited by the addition of anti-bFGF 
(Figure 1). The expression of an exogenously added MyoD gene does not affect the 
replication of serum starved adult and newborn SMC in the presence or absence of bFGF 
(Figure 2). 
After balloon catheterization it is shown that the morphology of the neointimal SMC 
closely resembles that of cultured newborn SMC (Schwartz et al., 1990). It is imaginable 
that this morphology corresponds with proliferative SMC already sensitized by bFGF. If 
newborn SMC in vitro represents this proliferative state, bFGF addition will not greatly 
stimulate replication. This is indeed what we found. Furthermore, we did not observe 
transcription of the bFGF gene in newborn SMC whereas in adult SMC the bFGF gene 
is transcribed and its level is markedly raised when bFGF is added (Figure 3). 
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The observed difference in replication stimulation of bFGF in newborn and adult SMC 
can not simply be explained by the absence or presence of FGFRs as our ligand binding 
data show: both in infected and uninfected newborn and adult SMC a 130 kD and 160 
kD ligand binding signal is present (Figure 6). We investigated possible relationships 
between the type of FGFR expressed and the observed response after bFGF addition by 
studying the expression of the different FGFRs in cultures of infected and uninfected 
newborn and adult SMC. Fig transcription is detected in all cultures. However, Fig 
mRNA is expressed more abundantly in uninfected adult SMC than in any of the other 
cultures (Figure 4a). 
The level of bek mRNA is much lower than that of Fig mRNA in our SMC cultures. 
Nevertheless, on poly A* RNA Northerns we could detect bek transcripts in all SMC 
cultures (Figure 4b). A cDNA clone coding for the entire extracellular region of bek 
hybridized with a 4.5 kb mRNA and also with a mRNA of about 6 kb in all lanes 
(Figure 4b). The nature of this 6 kb hybridization signal is unknown. A high molecular 
weight hybridization signal for bek also is observed in keratinocyte RNA (Avivi et al., 
1991). We also observed a hybridization signal of about 4.2 kb in RNA isolated from 
infected newborn and infected adult SMC. A band of this size could correspond to the 
RNA coding for the bek variant with two Ig-like domains (Houssamt et al., 1990). 
Champion-Arnaud et al. (1991) described that the bek premessenger is spliced in one of 
two mutually exclusive manners to form either the bek transcript or the K-sam transcript. 
However, in our infected adult SMC cultures both the bek transcript and the K-sam 
transcript were detected (Figure 5). These are complex data: when using these small-
sized bek exon and K-sam exon specific probes we did not detect any hybridization signal 
in newborn SMC, infected newborn SMC and adult SMC (Figure 5). However, a 
hybridization signal was detected in all cultures when that same Northern blot was 
hybridized with a bek cDNA probe coding for the entire extracellular domain (Figure 
4b). Hybridization of the Northern blot with a Fig cDNA as probe showed that the 
observed hybridization signal did not arise by cross hybridization with the Fig mRNA 
which appeared to be smaller in size (results not shown). These results suggest the 
presence of a FGFR mRNA in newborn, infected newborn and adult SMC highly 
homologous to bek that does not contain the ôe/t-specific exon or the K-iam-specific 
exon. In infected adult SMC both the bek exon and the K-sam exon are detectable. This 
suggests that the expression of these exons is possibly induced by MDSN. Thus far, 
cDNAs coding for forms of bek containing respectively two and three Ig-like domains, 
and a potentially secreted form of bek containing only the first Ig-like domain were 
described (Dionne et al., 1990; Crumley et ai, 1991). Also coexpression of the mRNAs 
coding for the forms of bek with two and three Ig-like domains in the same cell 
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frequently is observed (Champion-Amaud et al., 1991). Werner et al. (1992) described 
the specific use of three alternative exons coding for the third Ig-Iike domain in the 
extracellular region of the Fig receptor. One of these Fig splice variants lacked the 
transmembrane domain and cytoplasmic sequences and encodes a secreted receptor. 
For FGFR-3 and FGFR-4 only forms with three Ig-like domains have been described 
thus far (Keegan et al., 1991; Partanen et al., 1991). We showed the presence of a 1.7 
kb hybridization signal in both infected and uninfected newborn and adult SMC when we 
hybridized with a FGFR-4 probe coding for the extracellular domain. The size of this 
mRNA matches the estimated size of a mRNA lacking the transmembrane domain and 
cytoplasmic sequences of FGFR-4. Variants of FGFR-4 lacking transmembrane domains 
and, therefore presumably secreted forms of this receptor have not been described and 
additional experiments are needed to clarify these observations. The physiological role of 
such a protein is also unclear. If the secreted protein still has the second part of the third 
Ig-like domain and thus the capacity to bind FGF it might block the action of FGF by 
preventing interaction with the membrane spanning form of the FGF-receptor. It also 
might act as an extra cellular reservoir of FGF. 
Our cultured SMC express FGFR-4, a FGF-receptor that does not bind bFGF 
(Partanen et al., 1991). Interestingly, FGFR-3 transcripts only can be detected in the 
newborn and infected-newbom SMC cultures (Figure 4c). Partanen et al. (1991) showed 
a high FGFR-Ì expression in brain, skin, intestine and heart of 17 - 18 week old human 
fetuses. However, blood vessels were not analyzed in this study. 
Clearly, our knowledge of the FGFR family members and their many variants caused 
by differential splicing is not yet complete. In summary, we showed that adult SMC 
differ from newborn SMC in several ways. Adult SMC express the bFGF gene. This 
gene is overexpressed in response to bFGF. Furthermore, adult SMC also overexpress 
the Fig gene. In contrast to its expression in newborn SMC, adult SMC do not express 
FGFR-3. Further experimentation is needed to understand the role of the various FGFRs 
in controlling differences between newborn and adult SMC. 
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Summary/Samenvatting 

Summary 
The vascular diseases atherosclerosis and hypertension are characterized by an abnormal 
growth of the smooth muscle cells (SMC) in the medial layer of the vessel wall. In 
'established' hypertension SMC of the medial layer of the blood vessel increase their 
DNA-content and, thus, become polyploid. This polyploidy occurs probably as an 
adaptation to the increased wall pressure and enables the cells to respond faster to wall 
stress by synthesizing additional connective tissue elements. 
In chapter 2 we investigated this effect of ploidy on transcription of several genes in 
aortic SMC cultures derived from newborn and adult rats. Diploid and tetraploid 
subcultures derived from newborn rats were analysed and a strict correlation between 
ploidy and the RNA expression was observed. A tetraploid SMC contained twofold more 
RNA compared to a diploid SMC. We also compared the mRNA synthesis for several 
genes in diploid and tetraploid SMC cultures derived from newborn rats and 
demonstrated a direct correlation between ploidy and the amount of mRNA that was 
synthesized. However, when homogenetically but phenotypically different SMC cultures 
derived from adult rats were assayed differences in gene expression levels of single genes 
were observed. These differences probably reflected differences in the differentiation 
state of these cells. 
The first step in the process ultimately leading to the formation of the atherosclerotic 
plaque, is the thickening of the intimai layer of the blood vessel. This thickening is 
caused by replication and migration of the SMC in the medial layer of the vessel wall. 
There is a body of evidence that these events are driven by the action of growth factors. 
Much attention nowadays is focussed on the action of basic fibroblast growth factor 
(bFGF). bFGF is stored in large quantities in the extracellular matrix of endothelial cells 
and is released during vessel wall injury. Observations, both in vitro and in vivo, showed 
that bFGF is highly mitogenic for SMC. At present it is unclear whether bFGF acts on 
all SMC or whether there is a subpopulation of SMC for which bFGF is predominantly 
mitogenic. There is weak evidence that the SMC in the vessel wall might be 
heterogeneous. Cultured rat aortic SMC derived from the aorta of newborn rats strongly 
resemble SMC cultured from the neointima of wounded adult rats and differ completely 
from the phenotype of SMC cultured from the aortic medial layer of adult rats. The 
relationship between these phenotypes is unknown. However, the occurence of a 
"newborn" phenotype in the intima of an adult rat suggests a subset of immature SMC in 
the vessel wall, capable of replication and differentiation in response to injury. 
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In chapter 3 aortic SMC cultures derived from newborn and adult rats were infected with 
a retroviral construct containing a MyoD cDNA. MyoD is a master regulatory gene for 
myogenesis that converts many cultured cells of mesodermal origin to the skeletal muscle 
phenotype when serum is taken away from the culture medium. It was demonstrated that 
rat aortic SMC did not contain MyoD homologous mRNA. Expression of the 
exogeneously supplied MyoD gene in SMC cultures of newborn and adult rats converted 
these cells to elongated myoblasts and myotubes. It was demonstrated that these cells 
expressed a variety of skeletal muscle genes. In the presence of bFGF during growth and 
serum starvation MyoD-conversion completely was inhibited in SMC derived from 
newborn rats. In contrast, in SMC derived from adult rats the presence of bFGF highly 
increased the conversion frequency. 
In chapter 4 experiments are dealt with which were designed to clarify the observed 
differential effect of bFGF on MyoD-conversion in SMC cultures derived from newborn 
and adult rats. It was demonstrated that bFGF only was a mitogen for SMC cultures 
derived from adult rats. In these cells bFGF also stimulates its own mRNA synthesis. In 
SMC cultures derived from newborn rats these bFGF-effects did not occur. However, 
SMC derived from newborn rats did contain bFGF-binding sites. Ligand-binding 
experiments with radioactively labelled bFGF showed 130 kD and 160 kD bFGF-
receptor complexes in all cultures. Subsequently the presence of mRNA coding for the 
four FGF-receptor genes was investigated. These experiments gave the following results: 
Fig is the most predominantly transcribed FGF-receptor. Fig mRNA expression is higher 
in SMC from adult rats. Век expression was low in both MyoD-virally infected and 
uninfected SMC cultures derived from both newborn and adult rats. The expression of 
FGFR-3 was found solely in infected- and uninfected-cultures derived from newborn rats 
whereas the size of the FGFR-4 transcript suggested the existence of receptor variants 
not yet described in literature. All together suggest these results a complex regulation of 
the bFGF binding which largely is unsolved at this moment. 
104 
Samenvatting 
De vasculaire aandoeningen athérosclérose en hypertensie worden gekenmerkt door een 
abnormale groei van de gladde spiercellen uit de middelste laag van het bloedvat. Bij een 
langdurige en onbehandelde hypertensie neemt de hoeveelheid DNA in de kern van deze 
cellen toe. Deze zogenaamde polyploidisatie is waarschijnlijk een aanpassing aan de 
gestegen druk in het bloedvat aangezien polyploide cellen in staat zijn in een kortere tijd 
bindweefesel verstevigingen te synthetiseren. 
In hoofdstuk 2 hebben we het effect van deze Polyploidie op de transcriptie van enkele 
genen onderzocht in gladspierweefsel dat gekweekt is uit de aorta van jonge en 
volgroeide ratten. In diploide en tetraploide gladde spiercel subcultures van jonge ratten 
vonden we een correlatie tussen de ploidie en de RNA-expressie. Een tetraploide gladde 
spiercel bevatte ten opzichte van een diploide gladde spiercel dan ook een verdubbelde 
hoeveelheid RNA. We vergeleken ook de mRNA synthese van een aantal genen in deze 
kweken en vonden ook hier een directe correlatie tussen de ploidie en de hoeveelheid 
mRNA dat gesynthetiseerd werd. Echter, vergeleken we deze transcriptie niveau's met de 
transcriptie bij gladde spiercel kweken van isogenetische, volgroeide ratten dan werden 
bij een aantal genen wel verschillen in transcriptie niveau gevonden. Deze verschillen 
weerspiegelen waarschijnlijk verschillen in de mate van differentiatie van deze cellen. 
De eerste stap in het proces dat uiteindelijk leidt tot de vorming van de atherosclerotische 
plaque, is de verdikking van de intimale laag van de arterie. Deze verdikking wordt 
veroorzaakt door de replicatie en migratie van gladde spiercellen in de mediale laag van 
de bloedvatwand. Er zijn sterke aanwijzingen dat dit proces gestuurd wordt door 
bepaalde groeifactoren. Een belangrijke groeifactor in dit verband is de basische 
fibroblast groei factor (bFGF). bFGF is in grote hoeveelheden opgeslagen in de 
extracellulaire matrix van endotheelcellen en komt vrij bij beschadigingen van de 
vaatwand. bFGF is, zowel in vitro als ook in vivo, mitogeen voor gladde spiercellen. 
Echter, op dit moment is het onduidelijk in hoeverre bFGF op alle gladde spiercellen in 
de bloedvatwand aangrijpt of dat zich in het bloedvat een subpopulatie van gladde 
spiercellen bevindt die zeer gevoelig is voor bFGF. Er zijn enkele aanwijzingen die erop 
wijzen dat gladde spiercellen in de bloevatwand heterogeen zijn. Zo heeft 
gladspierweefsel zoals gekweekt uit de aorta van jonge ratten een morfologie die zeer 
sterk lijkt op die van gladde spiercellen, gekweekt uit de neointima van volwassen ratten. 
Deze morfologie wijkt sterk af van die van kweken verkregen uit de tunica media van 
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volgroeide ratten. Mogelijk bevindt zich in de media van volgroeide ratten een 
subpopulatie cellen, met een morfologie zoals die ook bij jonge ratten gevonden wordt, 
welke zorgdraagt voor het delend vermogen van de bloedvatwand na een verwonding. 
In hoofdstuk 3 wordt beschreven hoe gekweekte gladde spiercellen uit jonge en 
volgroeide ratten geïnfecteerd werden met een retroviraal construct dat een MyoD cDNA 
bevat. MyoD is een zogenaamd "master regulatory gene" voor de myogenese dat in staat 
is zeer vele gekweekte cellen, met een mesodermale origine, te converteren tot 
skeletspiercel. Deze conversie wordt ingezet op het moment dat het serum uit het 
kweekmedium wordt genomen. We hebben aangetoond dat in gladspierweefsel geen 
MyoD-homoloog mRNA voorkomt. Expressie van het retrovirale MyoD-construct, 
converteerde gladde spiercellen, zowel verkregen uit de aorta van jonge als ook van 
volgroeide ratten, tot myoblasten en myotubes. Deze geconverteerde cellen brachten een 
groot aantal skeletspier genen tot expressie. Echter, indien bFGF aanwezig was tijdens de 
groei, werd bij gladde spiercellen van jonge ratten geen conversie meer waargenomen. 
Echter, bij gladde spiercelkweken verkregen uit de aorta van volgroeide ratten, 
verhoogde de aanwezigheid van bFGF het aantal cellen dat converteerde enorm. 
In hoofstuk 4 worden experimenten beschreven die tot doel hadden het zojuist beschreven 
verschil in conversie bij gladde spiercelkweken uit jonge en volgroeide ratten, in 
aanwezigheid van bFGF, op te helderen. bFGF bleek alleen een mitogene werking op 
gladde spiercellen uit volgroeide ratten uit te oefenen. Alleen in deze cellen stimuleerde 
bFGF additie de bFGF-transcriptie. Echter ondanks het uitblijven van een effect na 
bFGF-additie. bevatten gladde spiercellen verkregen uit jonge ratten wel degelijk bFGF-
bindingsplaatsen. Ligand-bindingsstudies met radioactief-gelabelled bFGF toonden 2 
bFGF-receptor complexen aan met molecuulgewichten van 130 kD en 160 kD. 
Vervolgens werd gekeken naar het voorkomen van mRNA voor de verschillende FGF-
receptoren in de verschillende gladspierweefsel kweken. Deze experimenten gaven de 
volgende resultaten: op RNA-niveau is Flg de meest voorkomende FGF-receptor en Flg 
mRNA expressie is verhoogd in gladspierweefsel verkregen uit adulte ratten. Bek mRNA 
expressie was zeer laag in alle gladspierweefsel kweken. FGFR-3 expressie werd alleen 
gevonden in gladde spiercel kweken van jonge ratten terwijl de grootte van het FGFR-4 
transcript duidde op een nog onbekende receptor variant. Al met al wijzen deze resultaten 
op een zeer complexe regulatie van de FGF-respons welke grotendeels nog opgehelderd 
moet worden. 
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Eenvoudiger verteld 
In het lichaam transporteert het bloed onder andere voedingsstoffen, groeistimulerende 
factoren en zuurstof naar alle delen van het lichaam. Het bloed stroomt hiertoe, gerekend 
vanaf het hart. eerst door elastische slagaderen, dan door een fijn vertakt netwerk van 
haarvaatjes en vervolgens door van kleppen voorziene aderen terug naar het hart. Zoals 
alle organen zijn ook deze slagaderen uitstekend aangepast aan hun specifieke taak. Ze 
zijn opgebouwd uit een drietal lagen (zie figuur 1 op blz. 12). 
De laag die direct met het bloed in aanraking komt (de endotheelcellaag) zorgt er in de 
eerste plaats voor dat het bloed vloeibaar blijft dat wil zeggen dat de bloedstolling 
uitblijft. In de tweede plaats heeft deze laag een soort dakpan functie die verhindert dat 
het zo voedselrijke bloed uit het vat lekt, iets dat andere cellen maar tot ongewenste 
groei zou aanzetten. 
De tweede laag bevat veel gladde spiercellen en deze laag geeft het bloedvat zijn 
stevigheid. Een karakteristieke eigenschap van alle spiercellen, zo ook van deze gladde 
spiercellen, is dat ze kunnen samentrekken. Dit is erg belangrijk voor de handhaving van 
de gewenste bloeddruk. Immers, zou het vaatstelsel bestaan uit buizen met een 
gelijkblijvende diameter dan zou op het moment dat het hart samentrekt en het bloed het 
hart uitgeperst wordt, de bloeddruk even zeer hoog worden. Dit zou grote gevolgen 
kunnen hebben indien zich in het vat 'zwakke plekken' bevinden. Gelukkig kunnen de 
gladde spiercellen, mede door de door hen uitgescheiden elastine vezels het bloedvat 
tijdelijk wat uit laten rekken hetgeen een meer constante bloeddruk tot gevolg heeft. 
De buitenste laag verankert het bloedvat in het omliggende weefsel. Deze laag bevat zelf 
weer kleine bloedvaatjes die het grote vat van voedsel voorzien en zenuwvezels die 
helpen bij het gecoördineerd samentrekken van de gladde spiercellen. 
Aandoeningen van het bloedvat stelsel vallen uiteen in twee grote groepen. Ten eerste de 
'hoge bloeddruk' welke onder andere veroorzaakt kan worden door een veranderde 
hartwerking en een veranderde nierwerking (= zouthuishouding). Vaak zijn ook deze 
veranderingen gekoppeld aan het ouder worden. Het gevolg is dat het bloedvat zich gaat 
verdedigen tegen deze verhoogde bloeddruk: de gladde spiercellen gaan groeien en gaan 
meer verstevigingsvezels maken zodat het bloedvat dikker en stugger wordt. Dit is aan de 
ene kant prima ter versteviging van de zwakke plekken maar aan de andere kant is dit 
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een blijvende verandering die gekenmerkt wordt door een vergroting van de cel en een 
verdubbeling van het erfelijk materiaal (DNA) in de celkern zonder dat het tot deling 
komt. 
Een tweede groep bloedvat aandoeningen is in de volksmond bekend als aderverkaUdng 
(athérosclérose). Ook dit proces is gekoppeld aan het ouder worden alhoewel de eerste 
stadia ook al bij kleine kinderen waargenomen kunnen worden. Ook bij deze aandoening 
spelen de gladde spiercellen een voorname rol. Deze beginnen zich te vermenigvuldigen 
en schuiven op in de richting van het bloed waar ze een knobbel-achtige structuur 
vormen (de atherosclerotische plaque). Andere cellen en vetten (het bekende cholesterol) 
zetten zich af op die gladde spiercel knobbel. Uiteindelijk kan een bloedvat zo geheel 
afgesloten worden. Afhankelijk van welk bloedvat het hier betreft kan dit grote gevolgen 
hebben: vernauwingen en afsluitingen in de kransslagader, welke het hart van voedsel 
voorziet, kan leiden tot een hartinfarct. Athérosclérose leidt ook tot zeer zwakke plekken 
in een bloedvat hetgeen 'spontane' bloedingen tot gevolg kan hebben. Bijvoorbeeld in 
sommige bloedvaten in de hersenen kan dit grote gevolgen hebben (herseninfarct). 
Veel onderzoekers denken dat de gladde spiercellen door een beschadiging van de 
endotheel cellaag aangezet worden tot groei. Dit kan komen doordat de endotheelcellen 
bij beschadiging (bijvoorbeeld door een langdurige hoge bloeddruk maar vlak ook 'roken' 
niet uit) groeistimulerende factoren uitscheiden. Deze groeifactoren zijn nodig om 
beschadigingen en zwakke plekken in de endotheellaag te herstellen maar ze bereiken ook 
de onderliggende gladde spiercellen die dan op hun beurt zouden kunnen gaan groeien. 
Het aantal groeifactoren is echter zo groot en hun eigenschappen zijn zo ingewikkeld, dat 
we alleen nog maar onbewezen vermoedens hebben over het ontstaan van vaatziekten. 
We hebben gezien dat de gladde spiercellen bij beide ziektebeelden (hoge bloeddruk en 
athérosclérose) een belangrijke rol spelen. Het ligt dan ook voor de hand deze gladde 
spiercellen te bestuderen ten einde iets meer te weten te komen over de prikkels die hen 
aanzetten tot groei. De in dit proefschrift beschreven resultaten zijn verkregen uit 
experimenten met gladde spiercellen verkregen uit de hartslagader van onvolgroeide en 
volgroeide ratten. Deze cellen werden in plastic schaaltjes verder gekweekt. 
In hoofdstuk twee bekijken we het vermogen van gladde spiercellen met een verdubbelde 
hoeveelheid erfelijk materiaal (in ons geval verkregen door ze in een plastic schaaltje te 
kweken maar zoals al gezegd kan ook hoge bloeddruk dit soort veranderingen 
veroorzaken) tot het treffen van voorbereidingen tot eiwitsynthese (dit is de aanmaak van 
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het zogenaamde boodschapper-RNA). Het blijkt zo te zijn dat een verdubbelde 
hoeveelheid erfelijk materiaal inderdaad het vermogen heeft een verdubbelde hoeveelheid 
boodschapper-RNA aan te maken. Echter, gladde spiercellen uit jonge en oude ratten 
geven aanzienlijke verschillen te zien onafhankelijk van hun hoeveelheid erfelijk 
materiaal, iets wat waarschijnlijk verband houdt met het nog onvolgroeid zijn van jonge 
ratten. 
Dit brengt ons op een ander belangrijk punt. Tot nu toe is het niet echt duidelijk in 
hoeverre alle gladde spiercellen in een bloedvat van een volwassen dier hetzelfde 
vermogen hebben tot groei. Er zijn vage aanwijzingen (bij de mens en bij de rat) dat 
sommige cellen inderdaad een grotere bereidheid vertonen tot groei dan anderen. Bij de 
volwassen rat lijken deze uitgroeiende cellen dan ook heel sterk op de cellen zoals we die 
bij de nog groeiende rat aantreffen. In hoofdstuk drie zoeken we naar verschillen tussen 
deze gladde spiercellen van jonge en volgroeide ratten. We zien inderdaad 
groeiverschillen en onder bepaalde omstandigheden verschillen in hun groei na toediening 
van zo'n door endotheel cellen afgescheiden groeifactor (bFGF). bFGF speelt ook in de 
levende rat een zeer voorname rol bij endotheel herstel na beschadiging en heeft 
(misschien als nevenwerking) ook een groeibevorderend effect op het gladde 
spierweefsel. In hoofdstuk vier gaan we op zoek naar verschillen in het voorkomen van 
boodschapper-RNA en eiwitten die de aanwezigheid van bFGF herkennen. We vinden 
boodschapper-RNA voor sommige eiwitten bij beide celtypen en boodschapper-RNA voor 
een ander eiwit alleen bij gladde spiercellen van jonge ratten. 
Wat is nu het nut van deze studies? Het antwoord is onbevredigend als we kijken naar de 
directe toepasbaarheid ten aanzien van de beschreven bloedvataandoeningen. Echter, het 
onderzoek valt binnen het zogenaamde fundamenteel wetenschappelijk onderzoek en 
levert ons basale kennis over het mogelijke belang van groeifactoren en hun 
werkingsmechanismen hetgeen hopelijk op termijn het toepasbare onderzoek (bijvoorbeeld 
het ontwikkelen van medicijnen) voorspoediger kan laten verlopen. 
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